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Faithful DNA replication and repair are essential for maintaining genome stability and 
preventing various diseases including cancer. Both processes are executed by numerous 
redundant mechanisms to ensure that these processes are uninterrupted even when a 
primary mechanism fails. Despite this, they are not immune to challenges and failures 
leading to DNA damage and genome instability. These problems are more evident at the 
difficult-to-replicate regions of the genome such as the telomeres that cap and protect 
linear chromosome ends. Additionally, topological structures such as RNA:DNA hybrids, 
commonly referred to as R loops, can also present severe challenges to the DNA 
replication and repair machineries. Herein we report the functions of two distinct DNA 
replication and repair proteins—flap endonuclease 1 (FEN1) and ribonuclease H1 
(RNH1)—that preserve genome stability. First, we show that FEN1 limits telomere fragility 
in leading strand replicated telomeres. This is mediated by its flap endonuclease activity 
 ix 
independent of its gap endonuclease activity and C-terminal interactions. We show that 
the fragility phenotype is increased by RNA polymerase II inhibition and rescued by ectopic 
RNH1 expression. Because the telomere is transcribed and can form hybrids, these data 
suggest that the FEN1-mediated telomere fragility depends on RNA:DNA hybrids that 
accumulate from co-directional replisome-RNAP collision at the leading strand replicated 
telomere. These findings are the first to assign a leading strand specific function of FEN1, 
which is a canonical lagging strand protein. Second, we uncover a novel role for human 
RNH1 in DNA replication in the nucleus. We show that RNH1 depletion results in a global 
DNA damage response as well as telomere loss phenotype. Because RNH1 resolves 
RNA:DNA hybrids, we measured those hybrid levels and found that they increase upon 
RNH1 depletion. Given these hybrids could pose barriers to a moving replication 
machinery, we interrogated replication efficiency and discovered that RNH1 facilitates the 
replication fork movement, possibly by clearing hybrids. These data shed light onto the 
role of RNH1 in global DNA replication. Together, our work underscore the complexity of 
DNA replication and repair processes and highlight the varied roles that FEN1 and RNH1 
play to maintain genome stability.  
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Introduction  
Faithful DNA replication is crucial for maintaining genome stability. This is ensured by 
numerous complex and redundant mechanisms aimed at fulfilling various functions during 
replication. Redundancy is required to compensate for a function even when a primary 
mechanism fails to carry out its designated role. Despite this, replication is not immune to 
challenges and failure.  For example, variations in genome landscape and architecture 
such as regions of high GC content, repetitive sequences, or secondary structures 
produce difficult-to-replicate templates increasing the susceptibility to a replication 
dysfunction (1), (2). Similarly, DNA replication is also affected by genotoxic and cytotoxic 
agents in various forms from use of radiation and chemotherapy to exposure to 
environmental insults and food habits. These dysfunctions in DNA replication- either 
partial or complete - can lead to genome instability. Such problems are evident in many 
diseases including cancer, neurological disorders, and aging syndromes. In fact, these 
are the underlying causes of these diseases in many cases. Therefore, understanding 
the molecular mechanism of DNA replication, its dysfunction, and its repair is vital to 
developing therapies and advancing cures to multiple ailments.  
 
The structure of the genome yields valuable insights into DNA replication process. The 
genome in higher eukaryotes is packaged into linear chromosomes to maximize both the 
organizational and functional efficiency. Proteins of the histone family play an important 
role in this endeavor (3). Furthermore, the linear chromosomes are capped at their termini 
by nucleoprotein structures known as telomeres. Telomeres serve multiple functions to 
maintain genome stability. First, telomeres prevent chromosome ends from being 
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recognized as double strand breaks. Second, they minimize the physical loss of DNA 
from end-replication problem that arises from the inability of the lagging strand machinery 
to completely replicate the terminal end of a linear chromosome. Third, telomeres regulate 
access to replication and repair proteins. Despite a critical role that telomeres play to 
protect chromosomal integrity, they pose a significant challenge to the replication 
machinery. This is largely due to the G- rich repetitive nature of the sequences that can 
form G-quadruplex secondary structures (4). This problem is exacerbated by the absence 
of a compensating origin-firing from the opposite direction in the event of a centromere-
distal fork collapse leading to a loss of telomere (5). Therefore, several DNA replication 
and repair proteins along with the telomere specific proteins play an important role in 
minimizing these problems associated with the innately difficult-to-replicate telomere 
template.  
 
In addition to a sequence-specific challenges at the telomere, replication machinery also 
encounters several topological obstacles throughout the genome. One such challenge is 
RNA: DNA hybrids, commonly referred to as R-loops. An R-loop is formed when a 
nascent RNA emanating from an RNA polymerase hybridizes with a template DNA 
thereby producing a three-strand structure consisting of an RNA bound to a template DNA 
and a flanking non-template DNA (6). These structures are formed both at the telomeres 
as well as at other regions across the genome at a frequency much higher than previously 
appreciated. In recent years, these structures have received renewed interest due to the 
diverse and at times opposing cellular roles that they exhibit. While R loops play important 
physiological roles in diverse functions including during class switch recombination (CSR) 
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and RNA primer generation, they also pose significant threats to genome integrity (7), (8). 
Several studies have shown that RNA: DNA hybrids increase the rate of DNA mutation, 
DNA recombination, and impairment of replication and transcription (9). Therefore, cells 
have developed multiple mechanisms to either prevent or resolve such structures. 
Together, the findings that replication machinery faces both a difficult to replicate template 
such as a telomere as well as a topological challenge such as an R loop underscore the 
need for further investigation into replication process and its efficiency under various 
cellular stress to preserve genome stability. 
 
1. Eukaryotic DNA Replication and DNA Damage Repair  
 
1.1 DNA Replication  
DNA replication is a fundamental mechanism by which the genome is duplicated during 
cell division. The seminal discovery by Watson and Crick in 1953 revealed that the DNA 
structure was a double helix with two strands running antiparallel to each other (10). 
These findings laid the groundwork for various molecular insights into how DNA 
replication occurs. A few years later, an experiment performed by Meselson- Stahl proved 
the semi conservative nature of replication whereby a parent DNA strand acts as a 
template to produce a daughter strand resulting in a double strand daughter DNA 
composed of one old (parent) and one new (daughter) strand (11). In the last 60 years 
since, advancement in genetic tools, in-vitro biochemistry, and sequencing has identified 
numerous proteins and illuminated a detailed mechanism of DNA replication. 
Furthermore, these tools combined with a high-resolution microscopy have offered a 
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spatial and temporal insight into DNA replication. In addition to the detailed understanding 
of this process, these scientific advancements have allowed discovery and development 
of therapies to combat various diseases.  
 
The bulk of the DNA replication occurs during S-phase of the cell cycle and is carried out 
in 3 distinct phases: initiation, elongation, and termination. Each of these steps is a 
concerted effort of many proteins and is tightly regulated.  
 
Initiation 
Initiation of DNA replication begins in G1 and ends in early S-phase of the cell cycle. The 
first step of this process is the demarcation of the sites of replication initiation, commonly 
referred to as origins of replication. This is initiated by the binding of several proteins 
collectively referred to as Origin Recognition Complex (ORC). ORC binding serves as a 
platform for recruitment and assembly of Cdc6 (helicase loader), Cdt1 (chaperone), and 
the MCM2-7 (replicative helicase) complex, collectively referred to as pre-replication 
complex (pre-RC) (1), (12). This facilitates the loading of the helicase activators Cdc45 
and GINS to form CMG complex followed by the formation of pre-initiation complex, 
initiation of origin DNA unwinding by Mcm10, and subsequent activation of bidirectional 
replication forks. In lower eukaryotes such as budding yeast, ORC displays a degree of 
sequence specificity but in metazoans such as humans, binding is promiscuous (13), (14). 
Because DNA replication can only take place once per cell division, the replication 
machinery is under immense pressure to complete replication of the entire genome. This 
necessitates many origins to prime replication. As a result, for example, a budding yeast 
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genome of about 12 mega base pairs contains about 400 origins whereas a human 
genome of about 3 giga base pairs contains between 30,000 and 50,000 origins to 
replicate a vast amount of DNA (15).  
 
Elongation 
Elongation of DNA replication takes place in S phase of the cell cycle and involves the 
addition of deoxyribonucleotides to produce two daughter DNA strands. This process 
involves a careful co-ordination between replication initiation proteins and replisome 
complex consisting of core proteins including 11- subunit CMG helicase, topoisomerase, 
helicase, primase, DNA polymerase a-primase, leading strand polymerase e, lagging 
strand polymerase d, RFC clamp loader, Proliferating Cell Nuclear Antigen (PCNA) 
clamp, and single strand binding protein RPA (16), (17). Cdc45 plays an important role at 
the interface and transition of replication initiation into elongation. As part of the helicase 
activating complex, CMG, Cdc45 physically interacts with DNA template and is expected 
to play a role in recruitment of the DNA polymerases (18). The high resolution cryo EM 
studies of DNA-bound fly CMG and yeast CMG reveal Cdc45 complex structure is similar 
to that of Cdc45 crystal structure indicating that the groove inside the CMG complex is 
normally blocked and therefore would require further interactions for its opening and fork 
movement (19), (20). In fact, in vitro studies have shown that CMG directly interacts with 
both leading strand polymerase e and lagging strand polymerase d to maximize their 
replication efficiency (21). These findings also highlight an intricate interaction that must 
occur with diverse proteins to initiate elongation stage of DNA synthesis. A simpler model 
of replication exists in bacteria whereby a duplex DNA is unwound by DNA helicase at 
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the leading edge of the replication fork, with replicative DNA polymerase trailing (22).  In 
eukaryotes, however, this process is complex with a leading strand polymerase anchored 
directly on the front of the helicase while the lagging strand polymerase and primase 
complex is linked at the back of the helicase (23). 
 
Each DNA double helix consists of two strands- Leading and lagging- that run antiparallel 
to each other. Their replications differ on two key fronts. First, because the synthesis of a 
new DNA strand can only occur in a 5’ to 3’ direction, DNA replication of a leading strand 
(3’-5’ strand) occurs in the direction of replication fork movement and is continuous 
whereas that of a lagging strand (5’-3’ strand) occurs in the opposite direction of the 
moving fork and is therefore, discontinuous (24). As a result, lagging strand replication 
produces DNA fragments (180 and 200 bp in eukaryotes) called Okazaki fragments that 
are subsequently processed and joined together by several enzymes including DNA 
ligase and Flap endonuclease 1 (FEN1) to generate a new strand. Another significant 
difference between the replication of leading and lagging strand involves the utilization of 
different DNA polymerases. DNA polymerase e (Pol e) is responsible for bulk of the 
leading strand replication whereas DNA polymerases a (Pol a) and d (Pol d) are 
responsible for initiation of lagging strand replication and its elongation and maturation 
respectively.  
 
DNA replication on both strands is initiated by a 7-10 nucleotide long RNA primer that is 
synthesized by DNA polymerase a- primase. Pol a extends these by about 15 
deoxynucleotides and hands the replication task over to Pol e and Pol d for replication of 
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leading and lagging strands respectively (25). Replication fidelity is key to the massive 
task of completing replication of a vast genome. All eukaryotic DNA polymerases can add 
between 1000 to 2000 nucleotides of DNA per minute. However, pol e and Pol d have a 
much higher fidelity (1 error per 106-107 nucleotide synthesis) compared to Pol a (1 error 
per 104- 105 nucleotide synthesis). It is for this reason that the bulk of the replication is 
carried out by Pol e and Pol d after initiation by Pol a. The main reason for a lower fidelity 
of Pol a is because it lacks the proofreading exonuclease activity that the other two 
polymerases e and d  possess. DNA replication efficiency of these polymerases is also 
enhanced by a clamp loader protein PCNA by increasing their processivities (26). 
Replication is tightly regulated to ensure that replication takes place only once during a 
cell division. This is ensured by several cell cycle regulatory proteins such as Cdks to 
prevent secondary loading at the origin of replication sites. 
 
Termination 
DNA replication is terminated by a concerted effort of several proteins. It involves 
completion of DNA synthesis, decatenation of daughter DNA strands, and dissociation of 
replisome complex. While previous reports suggested that replication termination in 
eukaryotes was a result of accumulation of replication forks at the replication pause sites, 
it is, however, unclear if forks would stall and eventually terminate at those sites (27). 
Recent work suggests that the replicative helicase CMG plays an important role in 
termination whereby it is removed from DNA by the ATPase p97 following ubiquitation of 
MCM7 (28). This view is also contested because another study has implied that DNA 
replication can terminate even in the absence of CMG removal from DNA. To address 
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these competing hypotheses of replication termination, Walter’s group utilized in vitro 
Xenopus extract system and showed that DNA synthesis does not pause or slow down 
as two replication forks converge during termination (29). Instead, leading strands pass 
each other unaffected and position next to lagging strands before undergoing ligation. 
Moreover, they reveal that CMG helicase remains associated and is removed only after 
the ligation of the leading strand of one fork with the lagging strand of the opposite fork 
thereby negating a previously proposed model of unloading of CMG as a first step of 
termination. In addition, the new model suggests that decatenaton of daughter strands 
occurs concurrently with ligation before CMG unloading. According to this model, even if 
one fork stalls, it would remain stable until a converging fork arrives to ensure complete 
DNA synthesis by minimizing the possibility of premature replisome disassembly.  
 
1.2 DNA Repair  
Despite a high fidelity and robust proofreading capabilities of DNA polymerases and a 
tight regulation, DNA is not immune to damage that if not repaired can lead to genome 
instability. This can result from both internal and external sources such as failure in the 
part of replication proteins, natural replication challenges, and exogenous DNA damaging 
agents. Therefore, cells have evolved various repair mechanisms to sense such damage 
and repair it to ensure that the damaged DNA is not propagated through DNA replication 
and cell division. Various DNA repair systems work in tandem with the cell cycle 
regulatory machinery to that endeavor. Therefore, when DNA is damaged, DNA 
replication is halted and the DNA repair machinery is recruited to the site of the damage. 
If the damage is fixed, replication resumes (30). However, if DNA damage is unresolved, 
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cells can activate a cell cycle arrest to recruit additional factors to resolve it. In the event 
of severe damage or if the repair machinery fails to fix the lesion(s), a cell will either enter 
senescence or a programmed cell death to stop the damage propagation. 
 
DNA Damage Response (DDR)  
A coordinated cellular response to resolving damaged DNA is called a DNA damage 
response (DDR). DDR includes diverse repair systems, each with a task of repairing a 
distinct DNA lesion. DNA double strand breaks (DSBs) are the most severe forms of DNA 
damage because of their high mutagenic potential (31). Such DNA lesions are repaired 
mainly through one of two pathways- homologous recombination (HR) or non-
homologous end joining (NHEJ). HR involves utilization of a homologous template to 
recover genetic information that is lost during the initial breakage step or subsequent 
processing of DNA. HR initiates with resection of the broken ends from the 5’ to 3’ 
direction to produce a 3’ single stranded DNA (ssDNA) (32). Initial resection is carried out 
by the action of CtIP nuclease in concert with the Mre11, Rad50, and Nbs1 (MRN) 
proteins. This is followed by extensive resection by enzymes such as DNA2, which 
exposes a long stretch of ssDNA that is then bound by RPA. The function of RPA is to 
protect ssDNA from further degradation and recruit Rad51 recombinase to form a 
nucleoprotein filament. Once formed, nucleoprotein filaments containing Rad51 along 
with several other proteins such as Rad52, BRCA1 and BRCA2 are involved in homology 
search, strand invasion, displacement loop (D loop) formation and DNA synthesis to form 
a branched nucleic acid structure called a Holliday junction. These structures are then 
resolved through either double-strand break repair (DSBR) pathway producing crossover 
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products or synthesis-dependent strand annealing (SDSA) producing non-crossover 
products. Generally, HR results in non-crossover products to restore parent DNA 
sequence.  
 
In contrast to HR, NHEJ is a rapid but an error prone pathway for DSB pathway. It involves 
binding of Ku proteins (Ku70/80) to the broken ends followed by end processing and 
ligation by DNA ligase 4 (33). DNA protein kinase (DNAPK) plays an important role in 
signaling and recruitment of accessory proteins during NHEJ. In cells where NHEJ is 
blocked or inhibited, DNA double strand breaks can also be repaired by alternative NHEJ 
called micro-homology mediated end joining (MMEJ) (34). MMEJ involves resection or 
DNA unwinding to expose short, single strand microhomologies. Such microhomology 
sequences are then annealed and DNA repair is completed by cleavage of overhanging 
of 3’ flaps, DNA synthesis, and ligation. MMEJ utilizes ligase 1 and ligase 3 instead of 
ligase 4. Notably, MMEJ is mutagenic and therefore results in DNA deletions and loss of 
genetic information.  
 
In addition to DNA double strand breaks (DSBs), cells encounter several other types of 
DNA damage that are processed by distinct repair pathways. For example, ultraviolet 
light- induced DNA lesions and bulky DNA adducts are repaired by nucleotide excision 
repair (NER) (35). Nucleotide base lesions (single or multiple) are repaired by base 
excision repair (BER) whereas base mismatches are fixed by mismatch repair (MMR). 
Similarly, DNA crosslinks are repaired by Fanconi anemia (FA) pathway.  
 
	 12 
Regulation of the DDR 
DDR pathways are subject to tight regulation to ensure repair processes are only active 
at the right place and the right time. The regulatory network consists of DNA damage 
sensors, signal mediators, signal transducers and signal effectors, all working in tandem 
(36). The factors involved in post-translational modifications (PTMs) are a major part of 
this network. The most common forms of such modifications are phosphorylation, 
ubiquitination, acetylation, methylation, sumoylation and neddylation. In many cases, 
these modifications are reversible and therefore are a function of two opposing enzymes.  
 
Among a list of many proteins, two phosphatidylinositol 3-kinase related kinases (PIKKs)- 
ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3 related)- play a central 
role in DDR regulation. Upon DNA damage, the recruitment of the MRN complex to the 
DSBs triggers the auto-phosphorylation of ATM at S1981 turning it from an inactive dimer 
to an active monomer (37). ATR, on the other hand, is activated in response to replication 
stress and replication fork collapse and recruited to the DNA damage site upon binding 
of Rad9-Hus1-Rad1 (9-1-1) clamp complex (38). The activation of both ATM and ATR 
can lead to the phosphorylation of over 700 downstream substrates that are involved in 
various DNA damage responses including DNA repair, cell cycle progression and 
apoptosis (39). One of the well-studied substrates of ATM/ATR is histone H2A variant 
H2AX. It is an important sensor of DDR and when phosphorylated on S139, referred to 
as g-H2AX, it recruits plethora of DDR factors onto a damaged DNA to enact an 
appropriate response (40). The regulation of DDR via ATM/ATR is also closely 
coordinated with the cell cycle checkpoint kinases, Chk1 and Chk2, which transduce and 
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amplify the DDR signal. In fact, ATM directly phosphorylates and activates ChK2 in 
response to DSB while ATR phosphorylates Chk1 in response to several other DNA 
damages including single strand breaks (41). Additionally, ATM and ATR phosphorylate 
master regulator and central tumor suppressor protein, p53, thereby activating the 
transcription of several genes that regulate cell cycle arrest, DNA repair, senescence, and 
apoptosis (42). The interplay between master regulators of DDR including ATM, ATR, 
Chk1, Chk2, and p53 highlight the complexity and redundancy involved in DDR 
regulation.  
 
In addition to kinases, several other PTM factors play crucial roles in DDR regulations. 
Phosphatases such as WiP1 and PP2A directly regulate the activity of ATM, ATR, DNA-
PKcs, Chk1, Chk2, and p53 to antagonize the kinase signaling cascades (43). Similarly, 
ubiquitin E3 ligases such as RNF8 and RNF168 and deubiquitination (DUBs) enzymes 
such as USP, UCH, OUT, and MJD control ubiquitination of H2A histones to regulate 
DDR response (44), (45). In addition to ubiquitination, sumoylation is also emerging as a 
new mode of regulating DDR via PTM (46). 
 
Aside from PTM factors, non-coding RNAs (ncRNAs) are also evolving as key regulators 
of the DDR. This group of ncRNAs includes both the small ncRNAs such as microRNAs 
(miRNAs) and small interfering RNAs (siRNAs) as well as long ncRNAs such as XIST 
and HOTAIR. miRNAs, for example, are known to directly bind to the 3’UTR of p53 to 
disrupt its interaction with Mdm2 following DNA damage (47). Similarly, lncRNAs, for 
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example, interact with chromatin remodeling complexes to allow necessary response to 
DNA damage.  
 
2. Telomere biology 
 
2.1 Telomere structure and proteins 
Telomeres are the nucleoprotein structures that cap the termini of linear chromosomes in 
eukaryotes. They consist of telomeric DNA and proteins. Telomeric DNA length varies 
between organisms and can range from several hundred base pairs in yeast to tens of 
kilobases in mammals.(5) In humans, telomere length is between 5-15 kb whereas that 
in lab mouse, it is much longer in the order of 40-50 kb. In mammals, telomeric DNA is 
composed of G-rich –TTAGGG- hexanucleotide repeats. Although bulk of the telomeric 
DNA is double stranded, mammalian telomeres end with a distinct protrusion of a 50-300 
nucleotide single stranded repeats at the 3’end. These 3’ overhangs are called G-tails or 
G overhangs (48). By forming a secondary structure commonly referred to as t-loop 
(telomeric loop), these 3’ overhangs prevent telomeres from being identified as double 
strand breaks.  
 
In addition to the DNA, telomeres consist of many proteins. In mammals, telomeres are 
characterized by a basic complex of six proteins, referred together as shelterin complex 
(49). The Shelterin complex recognizes the dsDNA and the G-overhang and are 
responsible for sheltering telomeres from unwanted activities including the repair 
machinery that targets double strand breaks. Furthermore, the shelterin complex is 
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involved in facilitating t loop formation at the telomere. The proteins comprising the 
shelterin complex are telomeric repeat-binding factor 1 (TRF1), telomeric repeat-binding 
factor 2 (TRF2), repressor and activator protein 1 (RAP1), TRF1-interacting nuclear 
protein 2 (TIN2), protection of telomeres 1 (POT1), and POT1-and TIN2-interacting 
protein (TPP1). TRF1 and TRF2 bind the dsDNA while POT1 binds the single stranded 
3’ overhang. TIN2 and TPP1 are linker proteins that hold the complex together. Several 
interactions exist amongst these shelterin proteins to form a stable complex to maintain 
telomere integrity. For example, TIN2 interacts with TRF1, TRF2 and TPP1 and works as 
a lynchpin. TPP1 interacts with TIN2 and POT1 and forms a bridge to hold dsDNA and 
single stranded 3’ overhang together. RAP1 interacts with TRF2 to stabilize the complex. 
Importantly, all 6 proteins work in a coordinated fashion to ensure the proper replication 
and protection of the telomere.  
 
The physiological functions of the shelterin proteins are evident from various in-vitro and 
in-vivo studies (5), (50). TRF1 and TRF2 are both essential in mice. In addition, 
conditional deletion of either TRF1 or TRF2 results in destabilization of shelterin complex 
and telomere deprotection resulting in a telomeric DNA damage response. While they 
work as a unit, they also have specific functions during telomere replication. POT1 and 
TPP1 work together as a heterodimer, while TPP1 does not bind directly to the telomere, 
it is required to localize POT1 to the telomere as POT1 lacks its own nuclear localization 
signal. Additionally, TPP1 enhances the telomere-binding efficiency of POT1. POT1/ 
TPP1 heterodimers execute two major functions at the telomere- protection of 3’ G-
overhang and control of telomerase activity. First, by binding to the G-overhang, the 
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POT1/TPP1 heterodimer prevents RPA-binding at the G overhang and protect from 
activation of an unwanted ATR- mediated DNA damage response. Second, these two 
proteins have opposing functions in regulating telomerase activity; POT1 can block 
telomerase access to 3’overhang while TPP1 can recruit telomerase and stimulate its 
activity. However, how these two opposing activities are coordinated remains unclear. 
Another shelterin protein, TIN2, is involved in stabilizing the complex by binding to both 
TRF1 and TRF2. It also increases the DNA binding efficiency of both proteins. TIN2-
interaction with TPP1 is also responsible for facilitating the POT1-TPP1 interaction and 
POT1’s binding to the 3’ G-overhang. TIN2 also facilitates the interaction and recruitment 
of non-shelterin proteins to the telomere. Notably, TIN2 mutations are found in patients 
with short telomeres and those with dyskeratosis congenital. The final shelterin protein, 
RAP1, is unique in that it does not directly bind to the telomere DNA but with only TRF2. 
Furthermore, it is the only shelterin protein that is not essential in mice. However, its 
deletion results in increased recombination without affecting NHEJ or chromosomal 
fusions. Its function in humans is predicted to be slightly different from that in mice; it is 
expected to function with TRF2 to prevent NHEJ and chromosome fusion. RAP1, like 
TIN2, can also recruit or function with non-shelterin proteins, most notably in NFKB 
activation.  
 
In addition to the six primary proteins of the Shelterin complex, a growing list of other 
telomere-associated proteins have also been identified in mammalian cells. These non-
shelterin proteins either aid shelterin proteins or have their own independent functions 
during telomere replication, repair, and maintenance. For example, the CST protein 
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complex comprising of CTC1, STN1 and TEN1 in mammalian cells and Cdc13, Stn1, and 
Ten1 in S. cerevisiae bind to the 3’ overhang and function in telomere protection and 
replication (51), (52). Similarly, proteins of the RecQ helicases, WRN and BLM, interact 
with members of the shelterin complex and play a role in lagging strand telomere 
replication (53), (54). Additionally, our laboratory’s findings demonstrating the role of flap 
endonuclease 1 (FEN1) in telomere replication and maintenance highlight the diversity of 
non-telomere proteins that are recruited to telomeres (55), (56), (57). In addition to 
telomere DNA and proteins, telomeric RNA, commonly referred to as TERRAs, play an 
important role in telomere homeostasis either as free or bound to the telomere (58). 
 
2.2 Telomere replication and maintenance 
Telomeres must be replicated during S-phase to ensure cell division continuity. 
Telomeres are replicated primarily by one of two mechanisms: semi conservative DNA 
replication and by the action of the enzyme telomerase. In addition, there are two 
specialized mechanisms—recombination-based and alternative lengthening of telomeres 
(ALT) –which are activated under certain conditions in distinct cell types to maintain 
telomere lengths.  
 
Semi conservative telomere replication and challenges 
The most common mode of telomere replication in somatic cells is semi conservative 
DNA replication during which telomeres are replicated along with the rest of the genome. 
It is a multistep process that involves the movement of replication forks along the 
telomeric DNA on both leading and lagging strands followed by the processing of the DNA 
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ends to produce a terminal 3’ overhang structure. Replication machinery, however, faces 
two major challenges at the telomere compared to other loci in the genome (59). First, 
telomere replication is difficult due to its terminal location on the chromosome. While 
replication of any other genomic region is carried out by more than one replication forks 
originating from different origins, telomeres must be replicated by one centromere-distal 
replication fork. This can result in telomeres loss due to replication failure in the event of 
a fork collapse or damage. This problem is absent at other regions of the genome 
because a compensating replication fork traveling in the opposite direction can at least 
theoretically complete replication even when one fork collapses or is no longer functional. 
Furthermore, because telomere replication is thought to be initiated from origins located 
in the sub-telomeric region, replication machinery is under immense pressure to ensure 
that the last fired-origin replicate correctly (60). Failure to do so would result in incomplete 
telomere replication. Another major challenge in telomere replication emanates from its 
DNA sequence. Telomeres contain G-rich hexanucleotide repeats that form secondary 
structures such as G-quadruplexes and T-loops. Such secondary structures need to be 
resolved into a linear DNA molecule for replication to occur. While there are mechanisms 
for resolution of such structures, this makes DNA replication vulnerable to dysfunction 
resulting in incomplete replication or complete loss of telomeres. 
 
Telomere extension by telomerase 
Gradual telomere shortening is an inevitable consequence of semi conservative DNA 
replication and end-processing. Therefore, cells have evolved a mechanism to extend 
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telomeres to restore their lengths and facilitate cell division. This mechanism is a function 
of a specialized enzyme called telomerase.  
 
Telomerase is a ribonucleoprotein (RNP) complex comprised of two core subunits: 
telomerase RNA (TER) and telomerase reverse transcriptase (TERT) (61). TERT utilizes 
TER as a template to synthesize telomeric repeat sequences. While TERs are divergent 
in sequence and secondary structures amongst organisms, all TERS contain two 
common motifs- template/pseudoknot (PK) and TERT binding CR 4/5 domain. On the 
other hand, TERTs are evolutionarily conserved with four domains: the TERT N-terminal 
(TEN) domain, the TERT RNA binding domain (TRBD), the Reverse Transcriptase (RT) 
domain, and the C-terminal extension (CTE).  While the RT and the CTE domains are 
conserved between TERT and other reverse transcriptases, TEN and TRBD are unique 
to TERT.  
 
Telomerase, like other polymerases, catalyzes the addition of nucleotide to a primer 3’ 
hydroxyl group. However, telomerase is unique in its ability to interact with both its RNA 
template as well as the telomere DNA template. One notable difference is the ability of 
telomerase to extend without product dissociation from the enzyme, a process referred 
to as repeat addition processivity (RAP) (62). Furthermore, telomerase can copy the 3’ 
end of the template DNA with less base pairing compared to the 5’ end thereby increasing 
its efficiency. Furthermore, telomeric repeats containing RNA, commonly referred to as 
TERRA, is believed to play an important role in recruitment of TERT to short telomeres 
to facilitate their extension (63).  
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Telomere extension through the action of telomerase is vital during development in 
organisms. Therefore, telomerase activity is robust in embryonic stem cells as well as in 
somatic cells during development. However, this activity is significantly reduced or absent 
in adult human somatic cells (64). This results in progressive shortening of telomeres with 
each division in adults. The absence of telomerase in adult somatic cells has both 
beneficial as well as deleterious effects. For example, several human diseases including 
syndromes of bone marrow failure and pulmonary fibrosis arise from insufficient 
telomerase activity (65). In contrast, the absence of telomerase activity is a safeguard 
mechanism to preventing cancer as aberrant telomerase reactivation is directly linked to 
tumorigenesis (66). Therefore, the function of telomerase in telomere elongation is very 
consequential and underscores the importance of understanding its regulation in 
multitude of biological processes.  
 
Telomere recombination  
In addition to telomere elongation by semi conservative replication and by the action of 
telomerase, recombination is a pathway utilized by both yeast and mammals to maintain 
telomere length and for survival. Recombination-based telomere length was reported 
following an observation that some yeast cells lacking telomerase (est1D) had survived 
senescence and formed viable colonies (67). This was corroborated by the fact that 
deletion of recombination incompetent cells (rad52D) in est1D delta cells led to loss of all 
survivors. In addition to RAD52, all survivor cells require replication protein Pol32p 
suggesting that replication is a part of the recombination based telomere maintenance 
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(68). These survivor cells are broadly categorized into Type I and Type II (59). Type I 
survivors grow slowly and contain multiple Y’ sub telomere repeats and short terminal 
telomere repeats. In addition to RAD52 and POL32, type I survivors need RAD51, 
RAD54, RAD57, and most likely RAD55 for survival. Type II survivors, on the other hand, 
have few sub-telomere repeats but high degree of telomere repeat amplification. Type II 
survivors are also a result of type I transformations and require MRX complex, RAD59, 
and SGS1 helicase for survival. More recently, recombination based cellular survival in 
telomerase-negative cells is proposed to be regulated by TERRA and telomere RNA: 
DNA hybrids thereby highlighting the roles of TERRA in telomere homeostasis (69). 
 
Alternative lengthening of telomeres  
While 85% of all human cancers have active telomerase for maintaining telomere length 
and cell division, the remaining 15% utilize one or more mechanisms referred to as 
alternative lengthening of telomeres (ALT) (70). ALT is commonly found in tumors of 
mesenchymal origin such as glioblastoma multiforme, osteosarcomas, and some soft 
tissue sarcomas (71), (72). ALT cells are identified and characterized based on their 
several unique characteristics. One such prominent feature is the presence of telomeric 
DNA sequences, as independent DNAs separate from chromosomes. These are found 
as double stranded telomeric circles (t-circles), partially single stranded C-rich strands (C-
circles), linear double stranded DNA and t-complex structures with highly branched DNA. 
Another distinguishing feature of ALT cells is the presence of telomeric DNA in a subset 
of pomelocytic leukaemia nuclear bodies (PML). Such PML bodies are therefore, referred 
to as ALT-associated PML bodies and these are believed to play an important role in 
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several processes including senescence and DNA damage response. ALT cells are also 
marked by high level of telomere recombination and therefore telomere sister chromatid 
exchanges (T-SCEs) are abundant in ALT cells. Although still unclear, two current models 
exist to explain recombination-dependent telomere elongation in ALT cells. According to 
the first model called unequal T-SCE model, unequal T-SCEs occurs between a daughter 
cell with a longer telomere and another cell with shorter telomere thereby providing 
prolonged proliferative advantage to the cell population. The second model called 
homologous recombination-dependent DNA replication, which is a more favorable one 
proposes that ALT is a result of shorter telomeres undergoing homologous 
recombination-based synthesis. The substrate for telomere elongation, according to this 
model, can be a telomere from another chromosome, the same telomere or any linear 
extrachromosomal telomeric DNA pieces. Regardless of the model, ALT cells depend on 
several DNA replication and repair proteins including the MRN complex and shelterin 
complex proteins. Interestingly, a growing body of evidence suggests that telomere RNA 
(TERRA) and telomere hybrids play an important role in telomere maintenance in ALT 
cells (73). 
 
2.3 Telomere Physiology 
Telomeres are indispensable modules for maintaining genome stability. Despite robust 
cellular mechanisms aimed at replicating and protecting telomeres, they are not immune 
to challenges. Furthermore, gradual telomere attrition due to the “end replication problem’ 
can produce several consequences in the cell. Some of the most significant 
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manifestations are cellular senescence, cell death, and genome instability leading to 
several pathologies including cancer and aging disorders.  
 
Cellular senescence and apoptosis 
The most prominent consequence of telomere shortening and telomere damage is 
cellular senescence. It is a state of irreversible cell growth arrest along with several 
physiological changes. Telomere length is a primary determinant of cell division. When a 
telomere length reaches a critical length, primarily due to the end replication problem, 
commonly referred to as the Hayflick limit, a cell ceases to grow and undergoes growth 
arrest (74). Cells also become senescent when they sustain severe damage to the 
telomere or any other region of the chromosomes. Cellular senescence has both 
desirable as well as deleterious effects depending on the context. While it is a mechanism 
to suppress tumorigenesis at times of challenges from DNA damage as well as oncogenic 
stimuli, it can also promote pro-tumorigenic effects. Therefore, to prevent cellular 
senescence that can result from telomere shortening, cells utilize telomerase. This is a 
feature utilized by most cancer cells to achieve immortality. Ectopic expression of 
telomerase is also commonly used to immortalize cells for research purpose. However, 
telomerase cannot prevent cellular senescence that results in response to oncogenes 
such as RAS or DNA damaging agents. Furthermore, inactivation of the tumor suppressor 
genes such as p53 and pRb also prevents both human and mice cells from undergoing 
senescence in response to DNA damage and oncogenic RAS (75).  
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Apoptosis is another consequence of telomere dysfunction. It is a controlled cell death 
program activated when a cell sustains irreparable damage. Two tumor suppressors p53 
and pRb are critical components controlling the fate of a cell post DNA damage including 
post-telomere damage (76). Apoptosis, in many cases, is an alternative to senescence. 
For example, when both p53 and pRb are inactive, cells continue dividing until telomeres 
are extremely short. Cells at that state enter a phase known as crisis where they sustain 
chromosomal instabilities along with telomere attrition, resulting in apoptosis. However, 
some cells may still maintain their telomere lengths and hence escape apoptosis; these 
cells can proliferate indefinitely but are at a high risk for malignant transformation.  
 
Cancer and genome instability 
The importance of telomere maintenance in cancer is underscored by the fact that about 
85% of all cancers have activated telomerase and the remaining 15% have the ALT 
pathway of telomere elongation (75). Because telomere length can control cell division, a 
cancer cell must maintain its telomere length to enable its uncontrolled division to 
successfully establish a tumor and later metastasize. Telomerase expression in somatic 
cells has provided insights into direct relationship between telomere and cancer. Because 
telomerase expression is much higher in mice tissues compared to that in humans, mice 
are more cancer-prone than humans. Furthermore, telomerase co-operates with 
oncogenic stimuli to promote tumorigenesis as demonstrated by the requirement of 
telomerase in immunocompromised mice for tumor formation. Similar observations were 
also observed in transgenic mice whereby constitutive expression of telomerase in the 
skin promoted skin carcinogenesis (77). In addition, mutations in shelterin proteins are 
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well documented in numerous tumors (78). Similarly, numerous DNA replication and 
repair proteins including Ku 70/86, and Rad 51 have altered expression changes in 
cancers. These direct and indirect roles of telomere proteins in cancer underscore the 
significance of telomere protection in preventing tumorigenesis.   
 
Telomere dysfunction is also closely tied to genome instability, which is a hallmark feature 
of cancer. In fact, genome instability is a primary cause of many cancers (79). Specifically, 
loss of function of DNA replication and repair proteins as well as shelterin proteins are 
well-documented in several cases of genome instability and cancer. Telomeres play an 
important role in protecting chromosome ends and maintaining genome stability. When 
this protection is compromised due to internal and external challenges, chromosomes 
become unstable. When severe, it results in loss of genetic material due to chromosome 
breakage, fusions, and recombination. This can have deleterious effects including cancer 
development and cell death. Telomere dysfunction- caused by telomere shortening, 
telomere damage and loss of functions of telomere associated proteins- produces one of 
three outcomes for a cell: cellular senescence, cell death, or genome instability. Cellular 
senescence is a preferred state adopted by a cell in many cases to avoid genome 
instability. This can prevent division of cells with dysfunctional telomeres thereby guarding 
against tumor development. However, somatic mutations that accumulate with age can 
prevent activation of senescence. This is illustrated by studies showing loss of 
heterozygosity and mutations in the p53 tumor suppressor as well as RAS oncogene even 
in young and normal tissues (80), (81), (82). These cells fail to activate senescence or 
even apoptosis and in turn, result in genome instability that presents an enormous risk 
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for neoplastic transformation. A simple mutation or epigenetic change in these cells can 
result in transformation.  
 
Aging and non-cancer disorders 
Telomere dysfunction is also associated with aging and several other non- cancer 
pathologies. The effect of telomere shortening on senescence extends beyond a cell 
growth arrest. A senescent cell secretes a whole host of factors that are collectively 
referred to as the senescence-associated secretory phenotype (SASP) (83). The SASP 
can exert both cell-autonomous and non-autonomous effects and can change tissue 
homeostasis by altering cell integrity and function. The effects of SASP factors are studied 
in detail in fibroblasts, which are the major component of stroma. Senescent fibroblasts 
secrete many factors including enzymes that remodel extracellular matrix, cytokines that 
change the immune environment as well as growth factors that dictate cellular 
proliferation. These functions of senescent fibroblasts can have either beneficial roles in 
tissue homeostasis or detrimental consequences in various pathologies, including 
cancer.  
 
The importance of telomere integrity is also reflected by numerous non-cancer diseases. 
These diseases arise because of either mutations in specific telomere-related genes or 
due to changes in telomere length. Many premature aging syndromes manifest with 
mutations in one or more telomere genes. One such example is dyskeratosis congenital 
(DC) (84). DC Patients harbor mutations in the components of the telomerase complex 
that results in reduced telomerase stability and therefore shorter telomeres. DC is 
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classified as either autosomal dominant if mutations affect the TER gene or X-linked if 
mutation is on the dyskeratosis congenital 1, dyskerin gene (DKC1). DC patients display 
elevated levels of chromosomal instability and develop several pathologies including 
abnormal skin pigmentation, short stature, bone marrow failure, hypogonadism and 
infertility and premature death. These patients are also predisposed to spontaneous 
cancers. Other common premature aging syndromes include ataxia telangiectasia 
(mutations in ATM gene), Werner syndromes (mutations in WRN gene) and Bloom 
syndromes (mutations in BLM gene) with common features of shorter telomeres and 
genome instability. An important point is that patients with some of these premature 
syndromes have strikingly different phenotypes compared to the mice models of these 
diseases. This presents a challenge in interrogating molecular mechanism of these 
pathologies. In addition to diseases resulting from telomere related gene mutations, many 
age-related diseases have been identified due to their direct or indirect correlation with 
telomere lengths. Some of these disorders include heart failure, digestive tract atrophies, 
infertility, reduced angiogenic potential, reduced wound healing, and loss of body mass 
(85). Overall, manifestations of telomere dysfunctions through mutations of genes 
involved in telomere replication, telomere repair, and telomere maintenance highlight a 
diversity of roles telomere plays in genome stability and tissue homeostasis.  
 
 
3. R loops: Structure, proteins, and physiology 
 
3.1 Structure  
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RNA:DNA hybrids, commonly referred to as R-loops, are a three-stranded nucleic acid 
structure composed of an RNA-DNA hybrid and a displaced single stranded DNA. While 
R loops arise during several biological processes, the most accepted mechanism of R 
loop formation is transcription during which a nascent RNA emanating from an RNA 
polymerase hybridizes with a template DNA leaving a non-template DNA flanking. In vivo, 
R loops are formed as natural intermediates during the initiation of DNA replication in 
mitochondria, bacterial plasmids, the bacteriophages ColE1 and T4, and in 
immunoglobulin (Ig) class-switch recombination (CRV) (6). Depending on its origin, R 
loops can range from 8-10 base pairs to several thousand base pairs in length.  
 
R loop formation depends on three main features: G:C content, DNA supercoiling, and 
DNA cleavage (86). Using plasmid constructs in bacteria, it is well-established that 
clusters at the non-transcribed strand are required for initiation of R loop formation 
whereas the high G density region is required for stabilization and elongation of such 
structures. Similarly, negative supercoiling is considered an important factor for R loop 
formation in vivo. In fact, high negative superhelicity can reduce the G dependency. A 
third element, DNA cleavage or a DNA nick, is an important contributor of R loop formation 
based on findings that DNA nicks when placed downstream of the T7 promoter driving 
transcription enhanced R loop formation. Because an RNA strand would need to 
intertwine with the complementary DNA strand, negative supercoiling and high G content 
would make that event favorable by initiation of the bubble between DNA strands. Once 
formed, R loop is also favored by the fact that a RNA:DNA hybrid is thermodynamically 
more stable than a DNA duplex of identical length. 
	 29 
 
3.2 R loop proteins 
While naturally occurring R-loops have beneficial roles, undesirable R loop formation and 
stabilization have deleterious effects in the cells. Because replication and transcription 
occur simultaneously in higher eukaryotes, R loops by virtue of their large topological size 
can become a barrier to a moving replication fork as well as transcription apparatus. 
Similarly, R loops can induce DNA mutations on non-template DNA as well as increase 
the frequency of unwanted recombination (87), (88). Therefore, cells have evolved 
numerous mechanisms to either prevent the formation of undesirable R loops or to 
process them after their formation. To that end, several nucleases and helicases are 
tasked with the removal of R loops and hence prevent their accumulation. Ribonuclease 
H1 (RNH1) and ribonuclease H2 (RNH2) are two major nucleases implicated in the 
degradation of the RNA component of the hybrid (89). In yeast, both ribonucleases can 
resolve R loops and are therefore considered redundant in R-loop resolution. However, 
in humans, RNH1 is considered the primary enzyme responsible for R loop resolution 
while RNH2 is primarily tasked with the removal of single mis-incorporated ribonucleotide 
from DNA during DNA replication. Aside from nucleases, several helicases have also 
been identified. In humans, DNA helicase Pif1, RNA helicase DHX9, DNA/RNA helicase 
SETX, and RNA helicase AQR have all been shown to resolve R loops; their loss is 
associated with accumulation of R loops either in cells or mice models (90), (91), (92), 
(93). Similarly, accumulation of negative supercoiling is also associated with R loop 
formation. Therefore, enzymes that resolve negative supercoiling are deemed important. 
In yeast, cells lacking both topoisomerases Top1 and Top2 accumulate R loops in the 
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ribosomal DNA (rDNA) locus in addition to the stalling of RNA Polymerase and defects in 
pre-rRNA synthesis (94). In humans, cells deficient in TOP1 display DNA breaks and 
replication defects and these phenotypes are rescued by ectopic expression of RNH1 
thereby suggesting that TOP1 prevents R loop accumulation (95). Another mechanism 
involved in the prevention of R loop formation is a messenger ribonucleoprotein particle 
(mRNP) assembly complex. This involves numerous proteins involved in nascent RNA 
synthesis as well as mRNA export machinery. By directly or indirectly binding and 
protecting a nascent RNA, mRNP biogenesis proteins prevent its hybridization with the 
transcribed DNA strand. The first evidence of the role of mRNP biogenesis in prevention 
of R loop formation was provided by yeast studies which showed that yeast cells with a 
mutant THO complex, a part of the mRNP biogenesis, led to the accumulation of R loops 
(96). Similarly, another mRNP factor, SRSF1, is important for R loop prevention as 
evidenced by findings that showed that chicken DT40 and human HeLa cells depleted of 
SRSF1 showed elevated levels of rearrangements that were suppressed by RNH1 
ectopic expression (97).  In addition to mRNP factors, the mRNA surveillance system also 
prevents R loop accumulation as evidenced by the increased levels of R loops in yeast 
cells depleted of Trf4 as well as in mouse embryonic stem cells depleted of the 
exoribonucleases exosome components EXOSC3 and EXOSC10 (98), (99). 
 
3.3 R loops physiology 
Recent genome wide analyses have revealed that R loops are present throughout the 
genome at a frequency much higher than previously appreciated. Furthermore, it is 
becoming increasingly clear that R loops have a wide range of functions in transcription, 
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genome dynamics, and chromatin changes. Similarly, they are also implicated in 
numerous human diseases including cancer and neurodegenerative diseases.  
 
R loops in transcription 
The role of R loops in transcription is evident from genome wide mapping studies. R loops 
are present at both the promoter and termination regions of several genes. A genome-
wide capture of RNA:DNA hybrids followed by sequencing (DRIP-seq) revealed that R 
loops are enriched in CpG islands showing a strong GC skew (100), (101). Furthermore, 
R loops localize immediately after the transcription start site. Because these sites are hot 
spots for the action of gene-silencing DNA methyltransferase 3 B1 (DNMT3B1), R loops 
are believed to promote transcription activation of these genes. This hypothesis is also 
supported by the fact that regions of high GC skew are bound by methylated histones 
such as H3K4me3, H4K20me1 and H3K79me2 linked to transcription initiation and 
elongation.  
 
In addition to their roles in transcription activation, R loops are also associated with 
transcription termination. High GC skews are present at the 3’ end of some genes and 
the incidence of R loops in those regions raises a possibility that R loops are involved in 
protection from DNMTs just like in the promoter regions. In doing so, R loops may help 
avoid the transcriptional read-through and contribute to termination. In addition, roles of 
R loops in transcriptional termination are elucidated from their function in RNA pol II driven 
genes. The role of human SETX in XRN2-dependent termination is evidenced by 
accumulation of R loops at G rich termination pause sites upon depletion of SETX (92). 
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These data suggest that R loops at termination sites are required for RNA pol II pausing 
but subsequent removal would allow for release of RNA molecule and efficient 
transcription termination.  
 
R loops in genome dynamics  
Despite being key intermediates of various processes, R loops can modulate genome 
structure by inducing DNA damage and replication stress and by altering telomere 
dynamics. In doing so, R loops play an important role in genome instability. A non-
template DNA strand of an R loop is susceptible to mutations because it is more 
accessible to the action of mutagenic enzymes such as activation induced cytidine 
deaminase (AID), which can convert cytosine into uracil (102). Furthermore, R loop 
mediated DNA breaks, recombination, and chromosome rearrangements have been 
demonstrated in yeast and human cells. Because R loops are large topological structure, 
most of these DNA damage effects could be a result of the capacity of R loops to stall 
replication fork progression. R loops also interfere with the replication process in a 
transcription-dependent manner due to the collision of replication and transcription 
machineries in either co-directional or head-on directions. Additionally, recent findings 
that tumor suppressor proteins BRCA1 and BRCA2 are associated with R loop 
homeostasis suggest an expanded role of R loops in DNA repair and replication dynamics 
(103). 
 
R loops also play prominent roles at the telomere to protect chromosomal stability. 
Telomeric RNA, commonly referred to as TERRAs, hybridize with telomeric DNA to form 
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telomeric R loops. These R loops are equally important in both yeast as well as human 
cells. These R loops accumulate in yeast strains lacking RNase H or proteins of mRNP 
complex such as THO (104). Similarly, R loops play a critical role in maintaining telomeres 
in telomerase negative yeast cells whereby R loops activate recombination events that 
are necessary for telomere elongation and senescence delay (105). In human cells, 
telomeric RNA:DNA hybrids are important in cells that maintain telomere length via ALT 
mechanism, which requires R loops to initiate recombination (73). This highlights the 
varied roles that telomeric RNA:DNA hybrids play to maintain telomere integrity and 
prevent genome instability in yeast and human cells.  
 
R loops in human disease 
R loops are associated with numerous human diseases. The neurodegenerative 
disorders are one such group that has received a renewed interest. Multiple neurological 
disorders are caused by the expansion of trinucleotide repeats. Transcription of CTG 
repeats is shown to form R loop both in vitro and in vivo and this is linked to repeat 
instability in human cells (106). Similarly, FRDA is another neurological disease caused 
by expansion of GAA repeat in the first intron of FXN gene (107). In vitro studies and 
those in bacteria have revealed that RNA:DNA hybrids form on GAA repeat sequences 
leading to RNA polymerase arrest and reduced transcription of FXN expression. Similar 
R loop associated inhibition of transcription are also observed in FXS and fragile X 
associated tremor/ataxia syndrome (FXTAS) (108). In addition to direct role of R loops, 
R-loop removing enzymes are also implicated in various neurodegenerative disorders. 
For example, mutations of helicase SETX is associated with ataxia-ocular apraxia type 2 
	 34 
(AOA2) and with ALS type 4 (ALS4) (109), (110). 
 
In addition to neurodegenerative disorders, R loops are also important in cancer. This is 
largely because R loops are a source of genome instability and replication stress, both of 
which are hallmark features of cancer (111). An example of this is the role of tumor 
suppressors BRCA1 and BRCA2 in the prevention of R loop accumulation (103). Human 
cells depleted of BRCA1 or BRCA2 show elevated levels of R loops as well as double 
strand breaks, which are both rescued by ectopic expression of RNH1. In addition, there 
are various cancers with mutated R loop related genes whose functions remain unclear. 
One such example is a FIP1L1 gene that encodes a cleavage and poly (A) factor; it is 
affected by translocations between its amino-terminal domain and platelet-derived growth 
factor receptor a (PDGFRa) in 10-20% of eosinophilic leukemia cases (112). Similarly, 
another R loop linked protein, splicing factor SRSF1, is also overexpressed in several 
cancer types (113). Similar inferences can be made of results from cells infected with the 
cancer-causing Kaposi’s sarcoma associated herpesvirus (KSHV) (114). These cells 
have elevated DNA damage and increased R loops due to sequestration of RNA export 
factor TREX by a viral protein. It is unclear whether these R loop related genes have a 
causative link. Regardless, the role of R loops in genome instability and multiple cancers 
is undisputed and deserves further investigation.  
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Introduction 
DNA replication and repair are high-fidelity processes that maintain genome stability. 
Due to the importance of these processes, robust mechanisms have evolved to ensure 
they are completed even when components of the replication and repair pathways are 
compromised or absent due to mutation. In some instances, this compensation is 
inadequate. Indeed, mutations in specific replication or repair proteins give rise to 
genetic disorders such as ataxia telangiectasia, Bloom syndrome, and Fanconi anemia. 
Cells from these patients reveal that while gross DNA metabolism continues largely 
unabated, mild replication defects and sensitivity to DNA damaging agents or ionizing 
radiation contribute to genomic instability and increased cancer incidence (1,2). 
 
While the redundancy of replication and repair mechanisms ensures faithful replication 
of the bulk genome, regions with repetitive sequence or an ability to form secondary 
structures are problematic and thus particularly sensitive to mutations in DNA replication 
and repair proteins (3). This is best illustrated at common fragile sites, where replication 
stressors lead to replication defects and genomic instability. Why particular regions of 
the genome manifest as fragile sites remains obscure, but insufficient replication origins, 
repetitive sequences, and replication–transcription interference have all been implicated 
(4–6). 
 
Recently, telomeres have also been described as fragile sites because treatment with 
aphidicolin, a potent inducer of replication stress, results in reduced replication fork 
progression and abnormal telomere structures (7,8). In checkpoint-competent 
backgrounds, aphidicolin treatment increases telomere fragility by 1.5 to 4.5-fold (7–9), 
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while suppression of the ataxia and telangiectasia and Rad3-related (ATR) kinase is 
sufficient to induce a 1.7-fold increase in telomere fragility in murine Seckel cells (9). 
Telomere fragility is also induced in the absence of telomere-binding proteins that 
participate in telomere replication. Indeed, knockout of the Shelterin complex member 
TRF1, which is required for replication fork progression through the telomere, increases 
the rate of telomere fragility in murine cells by 3.0-to 4.5-fold (7,8,10); similarly, 
depletion of the CST complex members CTC1 or STN1, which are important for 
replication fork restart at the telomere, causes between a 2.0- and 3.0-fold increase in 
telomere fragility in human cells (11). 
 
DNA replication and repair proteins are also important in maintaining telomere stability 
by preventing or suppressing telomere fragility. We previously reported that depletion of 
flap endonuclease 1 (FEN1) results in a 2.0-fold increase in telomere fragility (12). Loss 
of the DNA glycosylase Nth1, which participates in the repair of oxidative stress-induced 
lesions, causes a 1.8-fold increase in telomere fragility (13). Helicases and 
topoisomerases also play roles in reducing telomere fragility. Depletion of TopoIIα 
causes up to an approximately 7-fold increase in telomere fragility, and depletion of the 
RecQ helicase BLM induces a 1.9-fold increase in telomere fragility (7,14). Similarly, 
RTEL1 depletion or deletion induces 2.3-fold and 4.0-fold increases in telomere fragility, 
respectively (7,10). These studies demonstrate the wide range of genetic manipulations 
that can induce telomere fragility with varying levels of severity. 
 
The mechanism(s) by which telomere fragility occurs is not clear, but the large number 
of proteins implicated in the phenotype suggests that multiple mechanisms exist. G-
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quadruplexes may play a role, as telomere fragility induced by RTEL1 deletion is 
exacerbated by treatment with the G-quadruplex-stabilizing drug TMPyP4 (10). Given 
these data, if the molecular event inducing telomere fragility occurs after the replication 
fork has passed, RTEL1-induced telomere fragility would be expected to exhibit lagging 
strand specificity; however, few studies have examined strand-specific telomere fragility. 
Sfeir et al. examined TRF1 knockout mouse cells using chromosome-orientation 
fluorescent in situ hybridization (CO-FISH), which is capable of distinguishing telomeres 
replicated by the leading versus lagging strand DNA replication machinery; they found 
that telomere fragility induced by loss of TRF1 did not exhibit strand specificity (7). 
Similarly, Chawla et al. identified UPF1, an ATPase and helicase associated with 
cytoplasmic RNA quality control, as a telomere binding protein; in UPF1-depleted cells, 
telomere fragility increased at both the leading and lagging strands, with a slightly larger 
increase observed at the leading strand (15). Most recently, Arora et al. demonstrated 
that ectopic expression of ribonuclease H1 (RNase H1) reduced fragile telomere 
formation on the leading strand in alternative lengthening of telomeres (ALT)-positive 
cells (16).  
 
Among the stressors the replisome encounters, transcription has a significant impact on 
DNA replication. Indeed, head-on collisions between the replisome and RNA 
polymerase (RNAP) are extremely damaging to the replication process (17). In contrast 
to head-on collisions, co-directional replisome–RNAP collisions in bacteria are more 
common and better tolerated by the cell (18,19). This may be due to a mechanism 
recently elucidated in viral and prokaryotic polymerases: following a co-directional 
collision with RNAP on the leading strand-replicated DNA, DNA polymerase III is 
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removed from the template, moves forward to the 3′ end of the nascent transcript, 
displaces RNAP, and restarts DNA synthesis using the transcript as a primer (20). 
Despite this mechanism, which would seem to permit damage-free replication across a 
region being transcribed, co-directional collisions between the replisome and RNAP can 
lead to unresolved RNA:DNA hybrids. If such collisions occur in mammalian cells, the 
RNA:DNA hybrids left behind would likely lead to DNA double strand breaks, an ataxia 
telangiectasia mutated (ATM)-mediated DNA damage response (DDR), and genomic 
instability (21,22). Thus, robust mechanisms would need to evolve to remove the 
RNA:DNA hybrids produced by a collision event. 
 
The known role of FEN1 in limiting telomere fragility (12), as well as the idea that 
telomere fragility might be the result of replication stress or interference with 
transcription, led us to explore the mechanism by which FEN1 reduces telomere 
fragility. We show that treatment with α-amanitin, which reduces the rate of RNAP 
elongation and thus may increase the rate of stochastic co-directional replisome–RNAP 
collisions, exacerbates the telomere fragility induced upon FEN1 depletion. Additionally, 
we find that the telomere fragility phenotype induced by FEN1 depletion and collision 
induction is RNA:DNA hybrid-dependent by rescuing telomere fragility with ectopic 
expression of RNase H1. FEN1’s role in limiting telomere fragility is distinct from its role 
in limiting sister telomere loss, as FEN1 depletion-induced telomere fragility is restricted 
to the leading strand. Neither FEN1’s classical replication role as mediated by its 
interaction with proliferating cell nuclear antigen (PCNA), nor FEN1’s DNA repair 
function mediated by its C-terminal interactions with numerous repair proteins are 
required for its activity in limiting telomere fragility. We find that FEN1’s gap 
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endonuclease and exonuclease activities are also dispensable for limiting telomere 
fragility, but that FEN1’s flap endonuclease activity is required. Our data support a 
model in which co-directional replisome–RNAP collisions on the leading strand-
replicated telomere produce RNA:DNA hybrid/flap structures that accumulate in the 
absence of FEN1. We propose that FEN1, a classical lagging strand replication protein, 
acts on the leading strand during telomere replication to resolve RNA:DNA hybrid/flap 
structures resembling Okazaki fragment substrates; in the absence of this activity, the 
subsequent replication stress and DNA damage manifests as telomere fragility. We 
believe this to be the first report placing an Okazaki fragment-processing protein 
explicitly on the leading strand during DNA replication. 
 
Experimental Procedures 
Cell culture 
Cells were cultured at 37 °C in 5% carbon dioxide and atmospheric oxygen, as reported 
previously (12,23,24). 293T cells and HEK 293 cells were cultured in high-glucose 
Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated fetal bovine 
serum (ΔFBS) and 1% penicillin/streptomycin (P/S) (Sigma-Aldrich, St. Louis, MO). BJ 
fibroblasts and BJ fibroblasts expressing Large T Antigen (BJL) were cultured in high-
glucose Dulbecco’s modified Eagle’s medium containing 15% Medium 199 (HEPES 
modification), 15% ΔFBS, and 1% P/S. RPE1 cells were cultured in Dulbecco’s modified 
Eagle’s medium (F12 modification) containing 7.5% ΔFBS and 1% P/S (Sigma-Aldrich, 
St. Louis, MO). Treatment with α-amanitin (Sigma-Aldrich, St. Louis, MO) was 
performed at 10 µg/mL for 12 hours prior to collection. All cell cultures were verified free 
of Mycoplasma contamination by PCR analysis. RPE1 cells were obtained from ATCC; 
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all other cells were obtained from Dr. Robert Weinberg (Massachusetts Institute of 
Technology). 
 
Virus production and infections 
Lentiviral production and transductions were carried out as reported previously (25). 
Briefly, 293T cells were transfected with an 8:1 ratio of pHR′-CMV-8.2ΔR packaging 
plasmid and pCMV-VSV-G, and a pLKO.1-puro plasmid carrying an shRNA using 
TransIT-LT1 (Mirus Bio, Madison, WI). Supernatant-containing virus was collected 48 
hours post-transfection and 72 hours post-transfection and filtered through a 0.45-μm 
PVDF membrane. Target cells were infected for four hours each on two consecutive 
days in the presence of 8 μg/mL protamine sulfate (Sigma-Aldrich, St. Louis, MO). 
Following infection, transduced BJ and BJL cells were selected with 1 μg/mL puromycin 
sulfate (Sigma-Aldrich, St. Louis, MO); transduced RPE1 cells were selected with 15 
μg/mL puromycin sulfate. 
 
Production of recombinant adenovirus type 5 was carried out using the AdEasy 
adenoviral vector system (Agilent Technologies, La Jolla, CA) according to the 
manufacturer’s protocol. Following collection of primary adenoviral stock, secondary 
and tertiary viral stocks were prepared by sequential infection of HEK 293 cells and 
purification from a cesium gradient. Briefly, infected cells were lysed in 0.5% Nonidet P-
40 and cell debris was cleared by centrifugation. Viral particles were precipitated from 
the lysate with 6.7% PEG 8000, 0.83 M sodium chloride, collected by centrifugation, 
and washed in PBS. Viral particles were suspended in 1.32 g/mL cesium chloride and 
centrifuged at 33,000 rpm for 18 hours at 4 °C in a swinging-bucket rotor. Intact viral 
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particles were collected from the cesium gradient, dialyzed in PBS, suspended in 33% 
glycerol, and frozen. Viral stocks were quantified using the AdEasy viral titer kit (Agilent 
Technologies, La Jolla, CA) according to the manufacturer’s instructions. 
 
Adenoviral transduction was carried out following lentiviral transduction. Cells were 
lifted, combined with concentrated adenovirus, and re-plated in media containing 
puromycin to select for lentiviral integration. Adenovirus was used at a multiplicity of 
infection of 20 on RPE1 cells. Following 48 hours of simultaneous selection and 
adenoviral infection, the media was replaced. 
 
Western blot analysis 
Western blots were conducted as described previously (26). Briefly, cells were washed 
with PBS and lysed in mammalian cell lysis buffer (100 mM sodium chloride, 50 mM 
tris-HCl pH 8, 5 mM EDTA, 0.5% Nonidet P40) supplemented with 2 mM dithiothreitol, 1 
mM Microcystin-LR, 2 mM phenylmethylsulfonyl fluoride, 1 mM sodium fluoride, 1 mM 
sodium orthovanadate, protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO), and 
phosphatase inhibitor cocktail set I (EMD Millipore, Billerica, MA). Following 
centrifugation, clarified lysate was quantified using the Bio-Rad Protein Assay (Bio-Rad, 
Hercules, CA). Lysates were resolved by SDS-PAGE and transferred to PVDF 
membranes for western blotting. The following antibodies were used: mouse 
monoclonal anti-Chk1 (sc8408, Santa Cruz Biotechnology, Santa Cruz, CA); rabbit 
monoclonal anti-Chk1, phospho-S345 (2348, Cell Signaling Technology, Danvers, MA); 
rabbit polyclonal anti-FEN1 (A300-255A, Bethyl Laboratories, Montgomery, TX); mouse 
monoclonal anti-RNase H1 (H00246243-M01, Novus Biologicals, Littleton, CO); rat 
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monoclonal anti-α-tubulin (ab6160, Abcam, Cambridge, UK); mouse monoclonal anti-β-
catenin (610154, BD Biosciences, San Jose, CA); rabbit polyclonal anti-γH2AX (07-164, 
Millipore, Billerica, MA). 
 
Metaphase chromosome preparation 
Metaphase chromosome spreads were prepared as described previously (27). Briefly, 
BJ and BJL fibroblasts were cultured in the presence of 0.1 µg/mL colcemid (Sigma-
Aldrich, St. Louis, MO) for five hours; RPE1 cells were cultured in the presence of 0.3 
µg/mL colcemid for four hours. Following arrest, metaphase cells were collected by 
mitotic shake-off, swollen in 75 mM potassium chloride, and fixed in 3:1 methanol:acetic 
acid. Chromosomes were spread by dropping onto glass slides and aged for 18 hours 
at 65 °C. When metaphases were to be analyzed by CO-FISH, 0.3 µg/mL of 5-bromo-
2′-deoxyuridine (Sigma-Aldrich, St. Louis, MO) and 0.1 µg/mL of 5-bromo-2′-
deoxycytidine (MP Biomedicals, Santa Ana, CA) were added to the culture media 18 
hours prior to collection of the cells. 
Fluorescent in situ hybridization (FISH) 
FISH was performed as described previously (27). Metaphase chromosomes were 
probed with a Cy3-(CCCTAA)3 (telomere) peptide nucleic acid (PNA) probe at 0.03 
µg/mL and a FAM-CENPB (centromere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand 
Oaks, CA) and mounted using ProLong Gold (Life Technologies, Grand Island, NY) with 
125 ng/mL DAPI (Sigma-Aldrich, St. Louis, MO). 
 
Chromosome-orientation FISH (CO-FISH) 
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CO-FISH was conducted as described previously (28) with modifications. Briefly, 
metaphase chromosomes were rehydrated and treated with 100 µg/mL RNase for 10 
minutes at 37 °C, rinsed, and re-fixed in 4% paraformaldehyde for 10 minutes at room 
temperature. Chromosomes were UV sensitized in 0.5 µg/mL Hoechst 33258 (Sigma-
Aldrich, St. Louis, MO) in 2x SSC for 15 minutes and exposed to 365 nm UV light for 60 
minutes using a UV crosslinker (Vilber-Lourmat, Marne-la-Vallée, France). 
Chromosomes were then digested with 3 U/µL exonuclease III (Promega, Madison, WI) 
for 15 minutes at room temperature, denatured in 70% formamide in 2x SSC at 72 °C 
for 90 seconds, and immediately dehydrated in cold ethanol before hybridization. 
Metaphase chromosomes were probed first with a FAM-(TTAGGG)3 (leading strand 
telomere) PNA probe at 0.03 µg/mL, then probed with a Cy3-(CCCTAA)3 (lagging 
strand telomere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand Oaks, CA) and 
mounted as described for FISH. 
 
 
 
Immunofluorescence (IF) and IF–FISH 
IF was carried out as described (29). For IF-FISH, following the completion of IF, the 
cells were probed as described for chromosomes above using a Cy3-(CCCTAA)3 
(telomere) PNA probe at 0.03 µg/mL (PNA Bio, Thousand Oaks, CA). Antibodies used 
were: rabbit polyclonal anti-γH2AX (07-164, Millipore, Billerica, MA) and goat anti-rabbit 
IgG–Alexa Fluor 488 (Life Technologies, Grand Island, NY). 
 
Fluorescence imaging 
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Chromosomes were imaged on a Nikon 90i epifluorescence microscope using a 100x 
1.40 NA Plan Apo VC objective (Nikon Instruments, Melville, NY) with Cargille Type FF 
or Cargille Type LDF immersion oil (Cargille-Sacher Laboratories, Cedar Grove, NJ) at 
room temperature. Cells were imaged using a 40x 1.0 NA Plan Apo objective (Nikon 
Instruments, Melville, NY) under the same conditions as those for chromosomes. Filter 
cube sets used were: DAPI-1160B-000-ZERO, FITC-2024B-000-ZERO, and CY3-
4040C-000-ZERO (Semrock, Inc., Rochester, NY).  Images were captured using a 
CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ). Individual channel lookup 
tables were auto-adjusted non-destructively and linearly, and images were deconvolved 
with a blind algorithm using NISElements AR (Nikon Instruments, Melville, NY) prior to 
quantification. 
 
RNA preparation and northern hybridization 
RNA was prepared using TRI Reagent (Life Technologies, Grand Island, NY). RNA was 
serially diluted, denatured as previously described (30), and spotted onto a Hybond-XL 
charged nylon membrane (GE Healthcare, Waukesha, WI) using a Bio-Dot 
Microfiltration apparatus (Bio-Rad, Hercules, CA) according to the manufacturers’ 
instructions. Samples were also treated with ribonuclease A (Roche Applied Science, 
Penzberg, Germany) and spotted to identify any DNA contamination in the RNA 
preparation. Following UV crosslinking, the membrane was prehybridized in northern 
hybridization buffer (15% formamide, 1% BSA, 100 mM sodium phosphate pH 7.7, 1 
mM EDTA, 7% SDS) for one hour at 65 °C. A purified 1.6 kb fragment consisting 
exclusively of vertebrate telomere repeats was random prime-labeled with [α-32P]dCTP 
(3000 Ci/mmol) using the High Prime DNA Labeling Kit (Roche Applied Science, 
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Penzberg, Germany) according to the manufacturer’s instructions to produce a 
telomere-specific DNA probe. Similarly, a purified cDNA of the human 5S ribosomal 
RNA was random prime-labeled to produce a 5S rRNA-specific DNA probe. Probes 
were purified using Illustra ProbeQuant G-50 Micro Columns (GE Healthcare, 
Waukesha, WI) and diluted to 1.2×106 dpm/mL in 10 mL of northern hybridization buffer. 
Probes were hybridized to the membrane overnight at 65 °C, after which the membrane 
was washed and imaged using either autoradiography or a storage phosphor screen 
and imager. Quantitation was performed in Fiji by first background subtracting the 
image and then computing the integrated density for each spot. 
 
Quantitative reverse transcription PCR (qRT-PCR) 
For qRT-PCR, cDNA was synthesized using Superscript III reverse transcriptase (Life 
Technologies, Grand Island, NY) according to the manufacturer’s instructions. qRT-
PCR was conducted using TaqMan Gene Expression Assays (Life Technologies, Grand 
Island, NY) according to the manufacturer protocol. Target genes used for verification of 
α-amanitin efficacy were MYC (Hs00153408_m1) and SIAH1 (Hs02339360_m1). 
Statistical analysis 
Telomere fragility events were defined as chromatid arms with telomere FISH signal 
observed as either multiple telomere signals or elongated smears as previously 
described (7). Fragility was counted in metaphase chromosome spreads; for each 
experimental condition, a minimum total of 600 chromosomes was counted. The 
minimum sample size was chosen based on its ability to consistently detect aphidicolin-
induced and FEN1 depletion-induced telomere fragility. Chromosomes completely 
lacking telomere FISH signal or exhibiting no strand specificity in CO-FISH (indicating 
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the technical issue of incomplete brominated strand digestion) were excluded and not 
quantified. Image groups were blinded prior to quantification. Two or more independent 
biological replicates were carried out for each experiment. 
 
Where data are shown as representative, the telomere fragility rate was computed for 
each metaphase chromosome spread (% fragile telomeres), and each experiment was 
statistically analyzed. Where data are shown as combined, telomere fragility rates were 
computed for each metaphase chromosome spread, and a normalized value was 
computed for each metaphase chromosome spread by dividing the raw value by the 
mean of the control values. The mean of the normalized values from each sample in 
two independent experiments was computed and graphed with error bars representing 
the standard error of the mean. For statistical analysis, raw values were centered by 
computing a t-statistic for each data point: the centered value for each chromosome 
spread was calculated by dividing the residual of each raw value relative to the control 
sample’s mean by the median absolute deviation of the control values. Centered values 
from two independent experiments were then combined for statistical analysis. Data are 
represented either by scatter plots with mean and standard error of the mean marked by 
a line and error bars, or by a bar graph with bars indicating the mean and error bars 
indicating standard error of the mean marked. 
 
For IF, γH2AX foci were counted in each nucleus. A minimum of 30 nuclei was counted 
for each condition in an experiment, and two independent biological replicates were 
combined for data quantification. Data are represented by a box and whiskers plot with 
the box marking 25th and 75th percentiles, line marking the median, whiskers marking 
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the 5th and 95th percentiles, and dots marking data points outside the 5–95 percentile 
range. 
 
For all data, p-values were computed using a two-tailed Mann-Whitney U test with a 
95% confidence interval in Prism 5 (GraphPad Software, La Jolla, CA). The Mann-
Whitney U test was chosen because not all samples exhibited normal distributions. All 
figures except the box and whiskers plot include standard error of the mean as an 
indicator of variance, and in all cases the variance within samples was similar. 
 
Results 
FEN1 depletion and transcription inhibition induce replication stress and a DNA 
damage response 
Because telomeres are transcribed to produce telomeric repeat-containing RNA 
(TERRA) (31,32), and because interference between replication and transcription is a 
known cause of genomic instability (5,33,34), we turned our attention to the impact that 
putative collisions between the replication and transcription machinery would have on 
telomere stability. Unlike in Schizosaccharomyces pombe, where transcription of 
telomeres and subtelomeres occurs using both strands as templates (35), mammalian 
telomeres are transcribed exclusively using the C-rich leading strand as a template 
(31,32); as such, co-directional collisions are the only type that can occur at the 
telomere. In bacteria, co-directional collisions are resolved by a mechanism that leaves 
behind an RNA:DNA hybrid/flap structure (20) which would need to be resolved in a 
eukaryotic cell to avoid a DDR and genomic instability (21,22). FEN1 has been 
previously shown to reduce telomere fragility (12), and the yeast FEN1 homolog 
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Rad27p can hydrolyze RNA flaps (36). We hypothesized that co-directional collisions 
are a molecular origin of telomere fragility, and that FEN1 can prevent post-collision 
RNA:DNA hybrid/flap structures from accumulating, causing damage, and ultimately 
leading to fragile telomere formation. 
 
To address this hypothesis, we first examined whether increasing the rate of stochastic 
collisions between the replisome and RNAP would increase replication stress and 
trigger a DDR in the context of FEN1 depletion. We treated BJ fibroblasts with the RNA 
polymerase II (Pol II) elongation inhibitor α-amanitin, a cyclic peptide toxin that reduces 
the rate of Pol II transcription approximately 100-fold, allowing chain elongation to 
continue without triggering transcript cleavage (37,38). We expected α-amanitin 
treatment to increase the frequency of stochastic collisions between the replisome and 
RNAP and thus increase replication stress and telomere fragility. Following transduction 
with a validated shRNA targeting the 3′-untranslated region of the FEN1 mRNA 
(shFEN1) (24) or a control hairpin (shCtrl), we treated BJ fibroblasts with either vehicle 
or 10 µg/mL α-amanitin for 12 hours and collected both RNA and protein lysates from 
the cells. qRT-PCR analysis confirmed the efficacy of α-amanitin treatment by 
quantitation of two short-lived transcripts, c-Myc and SIAH1. α-amanitin-treated control 
cells retained 2% and 6% of the c-Myc and SIAH1 mRNAs, respectively, compared to 
the levels observed in vehicle-treated control cells. Similarly, in FEN1-depleted cells, α-
amanitin treatment resulted in 4% and 10% of the levels of c-Myc and SIAH1 mRNAs, 
respectively, compared to vehicle-treated cells (Fig. 2.1A). Since transcription inhibition 
by α-amanitin might reduce steady-state TERRA levels and produce telomere 
phenotypes as a result of decreased TERRA, we carried out a northern blot analysis of 
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total RNA to detect TERRA. Because TERRA are expressed at low levels in BJ 
fibroblasts, we utilized a dot blot rather than a gel to maximize signal intensity and 
hybridized the membrane to a telomere repeat-specific probe; treatment with 
ribonuclease A was used to show the absence of contaminating DNA, and a 5S rRNA-
specific probe was used as a loading control. Northern analysis of vehicle- and α-
amanitin-treated cells demonstrated that the α-amanitin treatment conditions 
subsequently used for western and metaphase analysis did not impact steady state 
levels of TERRA in our system, demonstrating that the phenotypes resulting from the 
treatment were not due to a loss of TERRA, which are known to impact telomere 
stability (39,40) (Fig. 2.1B,C). 
 
To determine if Pol II inhibition induces replication stress and a DDR in the context of 
FEN1 depletion, we performed western blot analysis to examine phosphorylation of 
Chk1 at S345 and phosphorylation of histone H2AX at S139 (γH2AX), classical markers 
for the replication stress response and DDR, respectively. BJ fibroblasts transduced 
with the control hairpin and treated with vehicle displayed neither Chk1 phosphorylation 
nor H2AX phosphorylation (Fig. 2.2A). Treatment with α-amanitin induced a small but 
detectable increase in Chk1 phosphorylation, but did not induce γH2AX, indicating that 
α-amanitin treatment can induce limited replication stress, but is not sufficient to induce 
a DDR (Fig. 2.2A). Similarly, BJ fibroblasts depleted of FEN1 and treated with vehicle 
also displayed a small level of Chk1 phosphorylation and no detectable γH2AX (Fig. 
2.2A). Strikingly, upon treatment with α-amanitin, FEN1-depleted cells showed a robust 
phosphorylation of Chk1 and strong induction of γH2AX (Fig. 2.2A). 
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We also used IF to examine the formation of γH2AX foci in asynchronous BJ fibroblasts, 
and IF-FISH to assess the formation of telomere dysfunction-induced foci. 
Quantification of γH2AX foci demonstrated that while FEN1 depletion induced foci 
formation (2.14-fold in shFEN1+vehicle vs. shCtrl+vehicle, p < 0.0001), there was no 
change in γH2AX foci upon treatment with α-amanitin (Fig. 2.2B,C). Furthermore, we 
did not observe an increase in telomere dysfunction-induced foci in response to FEN1 
depletion or α-amanitin treatment (data not shown). These results indicate first that the 
amount of DNA damage induced in conditions that increase collision events causes a 
response only robust enough to be detected by the more sensitive western analysis. 
Second, they indicate that FEN1 depletion- and Pol II inhibition-induced replication 
stress and DNA damage is not restricted to telomeres; rather, DNA damage likely 
occurs throughout the genome wherever collisions occur. Thus, Pol II inhibition alone 
induces mild replication stress, and the depletion of FEN1 combined with Pol II inhibition 
results in a DDR that is not observed when FEN1 is depleted alone. 
 
Inhibition of transcription exacerbates the telomere fragility observed upon FEN1 
depletion 
We next examined whether the replication stress and DDR phenotypes observed in 
response to Pol II inhibition and FEN1 depletion manifest as telomere fragility. If failure 
by FEN1 to resolve the structures induced by collision events between the replisome 
and RNAP results in fragility, then we anticipated the rate of telomere fragility in α-
amanitin-treated and FEN1-depleted cells to mirror the replication stress phenotype. As 
before, we transduced BJ fibroblasts with either shCtrl (control) or shFEN1 and treated 
the cells with vehicle or α-amanitin for 12 hours prior to collecting metaphase 
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chromosomes. Consistent with our model, cells expressing shCtrl exhibited an 
increased rate of telomere fragility upon α-amanitin treatment (1.55-fold in shCtrl+α-
amanitin vs. shCtrl+vehicle, p = 0.0079) (Fig. 2.2D,E). When examining only the 
vehicle-treated cells, we found that as previously demonstrated, FEN1 depletion causes 
a significant increase in telomere fragility (2.15-fold in shFEN1+vehicle vs. 
shCtrl+vehicle, p < 0.0001) (Fig. 2.2D,E). Strikingly, FEN1-depleted cells treated with α-
amanitin displayed a significant 2.76-fold increase in telomere fragility when compared 
to control, vehicle-treated cells (shFEN1+α-amanitin vs. shCtrl+vehicle, p < 0.0001), 
and a significant 1.28-fold increase compared to FEN1-depleted, vehicle-treated cells 
(shFEN1+ α-amanitin vs. shFEN1+vehicle, p = 0.0017) (Fig. 2.2D,E). These fragility 
data mirror the Chk1 phosphorylation phenotype and support a model in which α-
amanitin treatment increases co-directional replisome–RNAP collision events that result 
in structures requiring FEN1 for resolution; without FEN1, the collision events generate 
replication stress, a DDR, and fragile telomere formation. These experiments suggest 
that FEN1’s role in limiting telomere fragility is dependent upon its ability to resolve 
structures produced by telomere transcription during DNA replication. 
 
Leading strand-specific telomere fragility is caused by RNA:DNA hybrids 
Our data above suggest a role for telomere transcription in telomere fragility induced by 
FEN1 depletion. Based on findings in prokaryotes, if co-directional collisions occur 
between the replisome and an RNAP, a structure resembling an Okazaki fragment with 
a segment of RNA:DNA hybrid would result (20); we postulate that if not resolved, this 
structure could give rise to fragile telomeres. Indeed, post-collision structures resemble 
R-loops, which are semi-stable displacement loops in which a nascent mRNA remains 
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hybridized to its DNA template, while the coding strand DNA remains single-stranded, 
resulting in replication stress and common fragile site expression (5). At common fragile 
sites, the enzyme RNase H1 suppresses replication stress phenotypes induced by R-
loop formation by hydrolyzing the RNA in RNA:DNA hybrids and thus resolving 
displacement loops (5). We reasoned that since the post-co-directional collision 
structure resembles an R-loop, RNA:DNA hybrids might be responsible for telomere 
fragility, and thus ectopic expression of RNase H1 should resolve the structure and 
telomere phenotype. Additionally, because our model predicts that the causative 
structure for fragile telomere formation occurs after the replication fork has passed the 
locus in question, we wondered if the telomere fragility observed upon FEN1 depletion 
manifests only on the leading strand, where collisions could occur. This question was 
especially prescient given that FEN1 is canonically a lagging strand replication protein, 
and has a previously established role in limiting sister telomere loss at the lagging 
strand (12). 
 
Following lentiviral transduction with a control hairpin (shCtrl) or FEN1-depleting hairpin 
(shFEN1), we transduced RPE1 cells with RNase H1 (Ad-RH1) (Fig. 2.3C) and 
collected cells for protein analysis and metaphase chromosome preparation. To identify 
if telomere fragility exhibited strand specificity, we used CO-FISH, a technique which 
exploits the fact that the C-rich and G-rich strands of the mammalian telomere are 
replicated exclusively by the leading and lagging strand machinery, respectively, 
allowing the use of strand-specific probes to identify which machinery replicated a given 
telomere on a metaphase chromosome (28). Strikingly, FEN1 depletion significantly 
increased leading strand-specific telomere fragility (2.30-fold in shFEN1 vs. shCtrl, p = 
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0.0021) (Fig. 2.3A,B) with no change observed on lagging strand-replicated telomeres 
(1.26-fold in shFEN1 vs. shCtrl) (Fig. 2.3A,B). Additionally, ectopic expression of RNase 
H1 rescued fragility on the leading strand-replicated telomere, returning fragility levels to 
those observed in control cells (1.19-fold in shFEN1+Ad-RH1 vs. shCtrl) (Fig. 2.3A,B). 
Given the specificity of RNase H1 for RNA:DNA hybrids, these data indicate that 
RNA:DNA hybrids lead to telomere fragility and suggest that the hybrid/flap structures 
that arise from co-directional collisions on the leading strand are responsible for the 
telomere fragility observed upon FEN1 depletion. Furthermore, given that RPE1 cells 
are telomerase-positive and telomerase expression rescues the sister telomere loss 
observed upon FEN1 depletion, these data indicate that FEN1’s role in limiting telomere 
fragility at the leading strand is distinct from its known role in limiting sister telomere loss 
at the lagging strand (12,24). 
 
α-amanitin is known to slow but not disengage the RNAP from the template strand 
(37,38), and its use would be expected to increase replisome–RNAP collisions and 
RNA:DNA hybrids.  Thus, we next wanted to determine if the fragility we observed upon 
α-amanitin treatment was also RNA:DNA hybrid-dependent. To address this question, 
we transduced RPE1 cells with Ad-RH1 (Fig. 2.4C) and treated the transduced cells 
with α-amanitin for 12 hours prior to metaphase collection. As before, α-amanitin 
treatment induced an increase in telomere fragility (1.79-fold in α-amanitin vs. vehicle, p 
= 0.0008) (Fig. 2.4A,B). As in the case of telomere fragility following FEN1 depletion, 
ectopic RNase H1 expression protected α-amanitin-treated cells from telomere fragility, 
resulting in levels similar to those observed in cells treated with vehicle (1.05-fold in Ad-
RH1+α-amanitin vs. vehicle) (Fig. 2.4A,B). Because α-amanitin treatment exacerbates 
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telomere fragility in the absence of FEN1 (Fig. 2.2D,E), the ability of RNase H1 to 
rescue fragility in both α-amanitin-treated (Fig. 2.4A,B) and FEN1-depleted cells (Fig. 
2.3A,B) suggests that FEN1’s role in limiting telomere fragility is to resolve RNA:DNA 
hybrid/flap structures that are produced following replisome–RNAP collisions. 
 
FEN1 flap endonuclease activity is required for limiting telomere fragility 
Given the unprecedented finding that FEN1 limits leading strand-specific telomere 
fragility, we sought to identify which of FEN1’s known functions were necessary for this 
activity. FEN1 possesses three unique enzymatic activities: an endonuclease activity on 
unannealed 5′ flaps consisting of either DNA or RNA, a weak exonuclease activity that 
cleaves nicks, gaps, or recessed 5′ ends of double-stranded DNA, and a gap 
endonuclease activity that cleaves double-stranded DNA at the 3′ end of a short single-
stranded gap (41–43). FEN1 is also known to interact with PCNA via a PCNA 
interacting peptide (PIP) box, directly pertaining to its role in DNA replication, and a 
number of DNA repair proteins via its C-terminus, pertaining to its role in base excision 
repair (44,45). We utilized a series of previously described FEN1 mutants that impact 
FEN1’s different roles in replication (D181A, ΔP, ΔPΔC) versus repair (ΔC, D181A, 
ΔPΔC, E160D) in genetic knockdown–rescue experiments (12,24) (Fig. 2.5A). To test 
whether the reduction in telomere fragility mediated by FEN1 requires its DNA repair 
functions, we used a lentiviral vector to express shCtrl (control) alone, shFEN1 alone, or 
shFEN1 simultaneously with the wild type (WT), ΔC, or D181A allele of FEN1 (Fig. 
2.5A); following transduction we prepared metaphase chromosomes. As before, FEN1 
depletion induced leading strand-specific telomere fragility (2.05-fold in shFEN3 vs. 
shLuc, p < 0.0001) (Fig. 2.5B,D). Expression of the WT allele of FEN1 rescued the 
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leading strand-specific induction of telomere fragility upon endogenous FEN1 
knockdown, indicating that the phenotype is specific to FEN1 knockdown (1.18-fold in 
shFEN1+WT vs. shCtrl) (Fig. 2.5B,D). Unexpectedly, expression of the ΔC allele also 
rescued FEN1 depletion-induced telomere fragility on the leading strand (1.02-fold in 
shFEN1+ΔC vs. shCtrl) (Fig. 2.5B,D). In contrast to the WT and ΔC alleles, the D181A 
nuclease-dead allele, which is deficient in all known nuclease activities (46,47), failed to 
rescue the phenotype, instead resulting in an increase in leading strand-specific 
telomere fragility comparable to the expression of shFEN1 alone (1.83-fold in 
shFEN1+D181A vs. shCtrl, p < 0.0001) (Fig. 2.5B,D). Neither knockdown of FEN1 nor 
expression of any of the mutant alleles of FEN1 altered the level of telomere fragility on 
the lagging strand, confirming that FEN1 does not play a role in the phenotype on 
lagging strand-replicated telomeres (Fig. 2.5B,D). These data indicate that FEN1’s flap 
endonuclease activity is required to limit leading strand-specific telomere fragility, but its 
interactions with several DNA repair proteins including WRN and BLM (deficient in the 
ΔC allele), and thus its DNA repair activities, are dispensable for this role. 
Consequently, FEN1’s ability to limit leading strand-specific telomere fragility is distinct 
from its previously described role in telomere stability, which depends upon FEN1’s C-
terminally mediated DNA repair activity to suppress sister telomere loss on the lagging 
strand-replicated telomere (12,24). 
 
Given that FEN1’s repair activity is dispensable for its ability to limit telomere fragility, 
and telomere fragility is associated with replication stress, we next investigated whether 
FEN1’s interaction with PCNA, and thus its replication activity, might be important in this 
role. To test this possibility, BJ fibroblasts depleted of FEN1 were transduced with the 
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WT, ΔP, ΔPΔC, or E160D cDNA of FEN1 (Fig. 2.5A). Analysis of telomere fragility on 
metaphase chromosomes revealed that as before, expression of the WT allele rescued 
the leading strand-specific induction of telomere fragility following FEN1 depletion (1.58-
fold in shFEN1 vs. shCtrl, p < 0.0001; 0.88-fold in shFEN1+WT vs. shCtrl) (Fig. 2.5C,D). 
Surprisingly, expression of both the ΔP and E160D constructs also rescued the fragility 
defect (0.77-fold in shFEN1+ΔP vs. shCtrl; 1.20-fold in BJ shFEN1+E160D vs. shCtrl) 
(Fig. 2.5C,D). Only the ΔPΔC allele, a functionally null allele due to its lack of nuclear 
localization, failed to rescue the leading strand telomere fragility observed upon FEN1 
depletion, resulting in an increase similar to that observed upon FEN1 depletion alone 
(1.61-fold in shFEN1+ΔPΔC vs. shCtrl, p < 0.0001) (Fig. 2.5C,D). As in the previous 
experiment, none of the FEN1 alleles induced lagging strand-specific telomere fragility 
(Fig. 2.5C,D). These data indicate that FEN1 requires neither its interaction with PCNA 
(deficient in the ΔP allele), nor its gap endonuclease and exonuclease activity (deficient 
in the E160D allele) to limit leading strand-specific fragility. In combination with the data 
from expression of the ΔC and D181A mutants, our experiments identify FEN1 flap 
endonuclease activity as necessary for its role in limiting telomere fragility. These data 
are consistent with FEN1’s known activities, as it has previously been shown to cleave 
flap structures with numerous modifications, including flaps composed of RNA 
(36,43,48). As such, our data and the literature support a model in which FEN1’s flap 
endonuclease activity could cleave the RNA:DNA hybrid/flap structures produced 
following a replisome–RNAP collision event (Fig. 2.6). 
 
Discussion 
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The role of FEN1 described here provides new insights into the breadth of its functions 
in maintaining genome stability. In addition to known roles in lagging strand DNA 
replication, base excision repair, and lagging strand telomere stability, we illustrate for 
the first time a role for FEN1 in leading strand replication. Furthermore, we have 
identified transcription as an important contributor to telomere fragility, and we have 
shown that FEN1 may resolve the RNA:DNA hybrid/flap structures resulting from 
collisions between the transcription and replication machinery. The strand specificity of 
telomere fragility observed in the absence of FEN1 shows that it has two independent 
molecular roles for promoting telomere stability: (1) FEN1 limits sister telomere loss at 
the lagging strand-replicated telomere by facilitating replication fork reinitiation (12), and 
(2) FEN1 limits telomere fragility at the leading strand-replicated telomere by resolving 
RNA:DNA hybrid/flap structures produced by co-directional replisome–RNAP collisions 
(Fig. 2.6). 
 
Though co-directional collisions between the replisome and RNAP are postulated to be 
less deleterious to DNA replication than head-on collisions, they still necessitate 
mechanisms to ensure replication fidelity. In bacteria, the primary replicative helicase, 
DnaB, translocates along the lagging strand template as it unwinds DNA ahead of the 
replication fork; as such, the helicase can move past an RNAP transcribing from the 
leading strand, which would result in an inevitable collision between the two 
polymerases (20). While accessory helicases such as Rep move along the leading 
strand template, this activity alone cannot prevent co-directional collisions (20,49). 
Bacteria thus can use a mechanism in which replication restarts on the leading strand 
template following a co-directional collision using the 3¢ end of the nascent mRNA as a 
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primer (20). Collisions between the replisome and RNAP also present a problem to the 
eukaryotic cell, where highly-transcribed Pol II and Pol III genes are known to impede 
replication fork progression (33,34). Extremely long genes that require more than a 
single cell cycle to transcribe are also known to induce collision events; these collisions 
induce common fragile site expression (5). Observations suggest that even though the 
eukaryotic replicative helicase, a complex of Cdc45, Mcm2-7, and GINS (CMG), 
translocates along the leading strand (50), its activity is insufficient to prevent collisions 
from occurring. Indeed, CMG is unable to bypass both biotin-streptavidin and Qdot (20 
nm) roadblocks on the leading strand (50). Even though the eukaryotic replicative 
helicase translocates along the leading strand, our data suggest that it is unable to 
bypass an RNAP and/or RNA:DNA hybrid on this strand. Together, these observations 
suggest that eukaryotes require a similar mechanism to that used by bacteria for the 
resolution of co-directional replisome–RNAP collisions on the leading strand. 
 
Although FEN1 has no known existing roles in leading strand DNA replication, our 
results provide an explanation consistent with the enzyme’s known substrates and 
activity. The putative RNA:DNA hybrid/flap structure produced following a co-directional 
replisome–RNAP collision is similar to the Okazaki fragment flaps FEN1 cleaves during 
lagging strand replication—differing only in that the flap is composed entirely of 
ribonucleotides. Thus, our model suggests that human FEN1 acts at the leading strand 
because co-directional collisions at the telomere only happen on the leading strand 
template. Because FEN1’s ability to limit telomere fragility does not require its C-
terminal domain, which interacts with the shelterin protein TRF2 to recruit FEN1 to 
telomeres during S and G2 phases of the cell cycle (24,51), it is unlikely that FEN1’s 
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ability to process post-collision structures is limited to the telomere. However, in other 
portions of the genome where replication begins from origins to either side of a 
particular locus, transcription could be more coordinated with replication to prevent 
head-on collisions from occurring. Wherever co-directional collisions occur, FEN1 is 
likely able to process the structures produced. 
 
Because the replication fork replicates the telomere in the centromere-to-telomere 
direction only, and because mammalian telomeres are only transcribed from the C-rich 
leading-strand template in the same direction (31,32), replisome–RNAP collisions at the 
telomere can only occur co-directionally. Our work here, as well as the fact that TERRA 
depletion induces telomere fragility (39), underscores the role of telomere transcription 
in fragile telomere formation. Indeed, work in yeast has shown that RNA:DNA hybrids 
produced by TERRA transcription promote recombination-mediated telomere elongation 
(40). In ALT-positive cells, RNase H1 has recently been shown to regulate the levels of 
RNA:DNA hybrids between TERRA and telomeric DNA (16). Like in yeast, TERRA 
RNA:DNA hybrids are hypothesized to promote recombination between ALT telomeres. 
In the absence of RNase H1, hybrids accumulate and promote excessive replication 
stress that causes fragile telomere formation and telomere loss; conversely, 
overexpression of RNase H1 reduces TERRA hybrids such that they cannot promote 
recombination, leading to progressive telomere shortening (16). Strikingly, the telomere 
loss that occurs following RNase H1 depletion in ALT cells is leading strand-specific 
(16). This work, when combined with ours, strongly implicates transcription-associated 
RNA:DNA hybrid formation at the telomere as a contributor to telomere fragility. 
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Despite the recency of telomere fragility as a defined phenotype, it has been identified 
in reports manipulating the expression of many proteins involved in DNA replication and 
telomere stability. ATR deficiency or depletion, BRCA2 deletion, RAD51 depletion, and 
RECQL1 depletion all induce elevated rates of telomere fragility (7–9,52,53). In addition, 
CTC1 and STN1, both members of the mammalian CST complex, limit telomere fragility 
(11). Like FEN1, these proteins participate in replication fork progression, replication 
fork reinitiation, and telomere stability. To our knowledge, no report has identified any 
perturbation that induces telomere fragility exclusive to the leading or lagging strand, 
though RNase H1 overexpression has been shown to reduce telomere fragility at the 
leading strand (16). Indeed, the lack of strand specificity in the telomere fragility 
produced by TRF1 deletion (7), as well as the involvement of G-quadruplexes (which 
form exclusively on the lagging strand) in RTEL1 deletion-induced telomere fragility 
(10), suggests that there are multiple mechanisms leading to fragile telomere formation. 
Our work underscores the complexity of DNA replication, and in placing the canonical 
Okazaki fragment-processing protein FEN1 at the leading strand, reveals the first 
molecular mechanism for fragile telomere formation on the leading strand. 
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Figure 2.1. α-amanitin treatment abrogates expression of mRNAs with short half lives 
but does not alter steady-state TERRA levels. (A) qPCR analysis of c-Myc and SIAH1 
mRNA expression in cells expressing a control hairpin (shCtrl) or FEN1-depleted cells 
(shFEN1), treated with either vehicle or α-amanitin (α-aman). mRNA levels in α-
amanitin-treated cells are shown as a fold change relative to the vehicle-treated cells. 
Fold changes were calculated using the ΔΔCt method; fold changes from two biological 
replicates were averaged to produce the graph. Error bars represent standard error of 
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the mean. (B) Northern dot blot to detect TERRA. RNA was isolated from cells 
expressing a control hairpin (shCtrl) or FEN1-depleted cells (shFEN1) that were treated 
with either vehicle or α-amanitin (α-aman). Serial dilutions of RNA were loaded onto a 
membrane. Samples treated with RNase A to control for genomic DNA contamination 
were also loaded (+RNase A). A telomere repeat DNA probe was hybridized to the 
membrane (telomere probe) to detect TERRA; the membrane was stripped and re-
probed with a 5S rRNA DNA probe (5S) as a loading control. The membrane was 
visualized with autoradiography. (C) Quantification of TERRA in cells treated with α-
amanitin. The northern dot blot in (B) was imaged with a phosphor imager and analyzed 
by densitometry using Fiji; TERRA levels in α-amanitin-treated cells are shown as a fold 
change relative to vehicle-treated cells. Two independent experiments were averaged to 
produce the graph; error bars represent standard error of the mean.  
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Figure 2.2. FEN1 depletion and transcription inhibition induce replication stress, a DNA 
damage response, and telomere fragility. (A) Western analysis of FEN1 expression, 
Chk1 phosphorylation (pS345), and H2AX phosphorylation (γH2AX) in control (shCtrl) 
or FEN1-depleted (shFEN1) cells treated with vehicle or α-amanitin (α-aman). β-catenin 
is shown as a loading control. (B) Quantification of γH2AX foci per cell. Two 
independent biological replicates were combined. The box marks the 25th to 75th 
percentile with the median marked by a horizontal line, whiskers mark the 5th and 95th 
percentiles, and dots represent values outside the 5–95 percentile range. p-values were 
computed using a two-tailed Mann-Whitney U test (***, p < 0.001 relative to shCtrl). (C) 
Representative immunofluorescence images stained with a γH2AX antibody (green) 
and DAPI (blue) from BJ fibroblasts expressing a control hairpin (shCtrl) or depleted of 
FEN1 (shFEN1). Cells were treated with vehicle or α-amanitin (α-aman) as indicated. 
The scale bar (white) represents 25 µm. (D) Representative quantification of the rate of 
telomere fragility. p-values were computed using a two-tailed Mann-Whitney U test (**, p 
< 0.01; ***, p < 0.001). Error bars represent standard error of the mean. (E) 
Representative metaphase chromosomes processed with FISH from BJ fibroblasts 
expressing a control hairpin (shCtrl) or depleted of FEN1 (shFEN1). Cells were treated 
with vehicle or α-amanitin (α-aman) as indicated. Centromeres are green and telomeres 
are red. Arrowheads mark fragile telomeres in the magnified images. 
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Figure 2.3. RNA:DNA hybrids are responsible for FEN1 depletion-induced leading 
strand-specific telomere fragility. (A) Representative metaphase chromosomes 
processed with CO-FISH from RPE1 cells expressing a control hairpin (shCtrl) or 
depleted of FEN1 (shFEN1), with or without ectopically expressed RNase H1 (Ad-RH1). 
Leading strand-replicated telomeres are green and lagging strand-replicated telomeres 
are red. Arrowheads mark fragile telomeres in the magnified images. (B) Representative 
quantification of the rate of strand-specific telomere fragility, with leading strand-specific 
telomere fragility shown in green and lagging strand-specific telomere fragility shown in 
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red. p-values were computed using a two-tailed Mann-Whitney U test (*, p < 0.05; **, p 
< 0.01). Error bars represent standard error of the mean. (C) Western analysis of FEN1 
and RNase H1 expression in control (shCtrl) or FEN1-depleted (shFEN1) cells, with or 
without ectopically expressed RNase H1 (Ad-RH1). Two exposures of the same RNase 
H1 blot are shown. α-tubulin is shown as a loading control. 
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Figure 2.4. RNA:DNA hybrids are responsible for α-amanitin-induced telomere fragility. 
(A) Representative metaphase chromosomes processed with FISH from RPE1 cells 
with or without ectopically expressed RNase H1 (Ad-RH1) and treated with either 
vehicle or α-amanitin (α-aman). Centromeres are green and telomeres are red. 
Arrowheads mark fragile telomeres in the magnified images. (B) Representative 
quantification of the rate of telomere fragility. p-values were computed using a two-tailed 
Mann-Whitney U test (***, p < 0.001). Error bars represent standard error of the mean. 
(C) Western analysis of RNase H1 expression in cells with or without ectopically 
expressed RNase H1 (Ad-RH1) treated with vehicle or α-amanitin (α-aman). Two 
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exposures of the same RNase H1 blot are shown. α-tubulin is shown as a loading 
control. 
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Figure 2.5. FEN1 flap endonuclease activity is required to limit leading strand-specific 
telomere fragility. (A) Schematic showing FEN1 alleles used in this study. Features 
indicated include a PIP box (PIP), nuclear localization signal (NLS), C-terminal region 
(C), and point mutations. The replication competency, repair competency, and ability to 
rescue telomere fragility (this study) of each allele are shown to the right. (B) 
Representative metaphase chromosomes processed with CO-FISH from BJL fibroblasts 
expressing a control hairpin (shCtrl) or depleted of FEN1 (shFEN1). Leading strand-
replicated telomeres are green and lagging strand-replicated telomeres are red. FEN1 
alleles were ectopically expressed where indicated. Arrowheads mark fragile telomeres 
in the magnified images. (C) Representative metaphase chromosomes processed with 
CO-FISH from BJ fibroblasts expressing a control hairpin (shCtrl) or depleted of FEN1 
(shFEN1). Leading strand-replicated telomeres are green and lagging strand-replicated 
telomeres are red. FEN1 alleles were ectopically expressed where indicated. 
Arrowheads mark fragile telomeres in the magnified images. (D) Quantification of 
strand-specific telomere fragility per chromosome, with leading strand-specific telomere 
fragility shown in green and lagging strand-specific telomere fragility shown in red. Two 
independent biological replicates were analyzed, normalized with shCtrl set to 1 for 
each mutant group, and combined. p-values were computed using a two-tailed Mann-
Whitney U test (***, p < 0.001 relative to shCtrl). Error bars represent standard error of 
the mean. 
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Figure 2.6. A model of FEN1’s role following co-directional replisome–RNAP collisions. 
(A) RNA Pol II (RNAP) transcribes TERRA from the C-rich leading strand. The 
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replisome approaches the transcription complex and a co-directional collision occurs. 
Pol II dissociates from the nascent TERRA. (B) The replisome moves to the 3¢ end of 
the TERRA, leaving a 5¢ RNA flap and RNA:DNA hybrid. (C) The replisome resumes 
replication of the leading strand using the 3¢ end of the nascent TERRA as a primer. (D) 
FEN1 cleaves the 5¢ RNA flap left behind by the collision. (E) FEN1’s cleavage leaves 
behind a gap and a stretch of RNA:DNA hybrid that can be repaired. (F) In the absence 
of FEN1, RNA:DNA hybrid/flap structures accumulate and lead to telomere fragility. 
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Introduction 
High-fidelity DNA replication is paramount to the maintenance of genome stability. 
Therefore, cells have evolved various redundant mechanisms to resolve genotoxic 
challenges including the presence topological structures. If not resolved, these 
structures can impede replication fork progression, leading to the stalling and eventual 
collapse of replication forks (1). One such structure is the RNA:DNA hybrid, commonly 
referred to as an R-loop. Mapping studies have revealed that RNA:DNA hybrid 
structures are present throughout the genome more frequently than previously 
appreciated (2, 3). One source of R-loops is transcription during which nascent RNA 
emanating from RNA polymerase II hybridizes with its template DNA (4). While these 
topological structures play a vital role in a number of key processes including class 
switch recombination (CSR) of immunoglobulin genes and transcription termination, 
their persistence or unscheduled formation and stabilization pose a significant challenge 
to genome integrity (5, 6). Because DNA replication and transcription occur 
simultaneously at many regions of genome, hybrids can form in front of the replication 
machinery and affect its progression. Indeed, these R-loops can lead to increased DNA 
mutations, unwanted recombination and gross chromosomal aberrations (7). Thus it is 
not surprising that a number of proteins inhibit the formation of these structures or 
resolve them once they have formed (4). Topoisomerase I and mRNA export and 
splicing factors, for example, play an active role in preventing R-loop formation (4, 8). 
On the other hand, the helicases Senataxin (SETX) and Aquarius (AQR), are tasked 
with resolving these structures to promote transcriptional termination and maintain 
genome stability respectively (6, 9). In addition, DNA damage response factors such as 
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breast cancer susceptibility factors (BRCA1 and BRCA2) are also implicated in 
preventing R-loop accumulation and the ensuing DNA damage (10, 11). 
 
Ribonuclease H1 (RNH1) is a specialized enzyme that can specifically resolve long 
RNA:DNA hybrids. A closely related protein complex, ribonuclease H2 (RNH2) is adept 
at removing single misincorporated ribonucleotides from DNA and is critical for ongoing 
genomic stability (12). In yeast, RNH1 and RNH2 function redundantly to facilitate 
efficient double strand break repair during homologous recombination by assisting in the 
unwinding of DNA strands and RPA binding (13). Ectopic expression of RNH1 in yeast 
is sufficient to minimize transcription-dependent hyper-recombination, pausing of the 
replication fork, and HU sensitivity (14, 15, 16). In mammalian cells, RNH1 has an 
established role in mitochondrial DNA replication, and its deletion is embryonically 
lethal, demonstrating that RNH2 cannot compensate in this setting (17, 18, 19, 20). 
RNH1 localizes to the mammalian nucleus (21) and ectopic RNH1 expression is 
routinely exploited in mammalian cells to resolve RNA:DNA hybrids. Recently RNH1 
was shown to prevent unwanted recombination events at telomere by resolving 
telomeric RNA:DNA hybrids in cells that utilize the ALT mechanism of telomere 
maintenance (22). Another recent study identified a link between DNA damage and the 
accumulation of RNA:DNA hybrids at the telomere (23). However, whether RNH1 plays 
a role in nuclear DNA replication outside of telomeres remains to be explored. 
 
Given the role of RNA:DNA hybrids in replication impairment and the ability of RNH1 to 
resolve such hybrids, we sought to determine if RNH1 impacts genomic integrity in the 
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mammalian nucleus and if so how. We depleted RNH1 from human cell lines and found 
that RNH1 depletion resulted in increased RNA:DNA hybrids, DNA damage response, 
and slowing of DNA replication forks. Importantly, these phenotypes were dependent 
upon RNH1 nuclease activity, suggesting that the hybrids were responsible for these 
phenotypes. Our studies uncover a novel role of RNH1 in the mammalian nucleus and 
extend its important function in nuclear DNA replication.  
 
Experimental Procedures 
Cell culture 
Cells were cultured at 37 C in 5% carbon dioxide and atmospheric oxygen, as 
previously reported (24). 293T cells were obtained from Dr. Robert Weinberg 
(Massachusetts Institute of Technology) and cultured in high-glucose Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% heat inactivated fetal bovine serum 
(FBS) and 1% penicillin/ streptomycin (P/S) (Sigma-Aldrich, St. Louis, MO). RPE1 
cells were obtained from ATCC and cultured in DMEM: Nutrient Mixture F-12 
(DMEM/F12) containing 7.5% FBS and 1% P/S.  
 
siRNA transfection  
siRNA transfection was performed using Invitrogen’s Lipofectamine RNAiMAX Reagent 
(Thermo Fisher Scientific) according to the manufacturer’s protocol. siRNAs used were 
control (siCtrl- Cat #4390843) or RNH1-directed (siRNH1- Cat #4390824, ID s48356) 
from Life Technologies or that directed to the 3’ UTR of RNH1 (siRNH1- hs.Ri. 
RNASEH1.13.1) from Integrated DNA Technologies.  
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Virus production, infections, and stable cell lines  
Lentiviral production and transductions were carried out as previously reported (25). 
Briefly, 293T cells were transduced with an 8:1 ratio of pHR -CMV-8.2 R packaging 
plasmid and pCMV-VSV-G and a pLKO.1-puro plasmid carrying an shRNA using 
TransIT-LT1 (Mirus Bio, Madison, WI). Supernatant-containing virus was collected 48 
hours post-transfection and filtered through a 0.45- μm PVDF membrane. RPE1 cells 
were infected for 4 hours each on 2 consecutive days in the presence of 8 μg/ml 
protamine sulfate (Sigma). Following infection, transduced cells were selected with 15 
μg/ml puromycin sulfate. Stable RPE1 cell lines were prepared by using either a GFP 
tagged D145N RNH1 construct (a generous gift of Dr. Marteijn) (26) or its wildtype 
version (modified from D145N construct using site directed mutagenesis, Agilent 
Technologies).  
 
Western Blot Analysis  
Western blot analysis was carried out as previously described with modifications (27). 
Briefly, cells were washed with PBS and lysed in radio-immunoprecipitation assay buffer 
(150 mM NaCl, 50 mM 1 M Tris-HCl, pH 8.0, 1.0% NP-40, 0.5% sodium deoxycholate, 
and 0.1% SDS) supplemented with 1 mM sodium orthovanadate, 1 mM sodium fluoride, 
1 mM microcystin-LR, 2 mM phenylmethylsulfonyl fluoride, protease inhibitor mixture 
(Sigma), and phosphatase inhibitor mixture set I (EMD Millipore, Billerica, MA). 
Following sonication and centrifugation, supernatant lysate was quantified using the 
protein assay (Bio-Rad). Lysates were subjected to a SDS-PAGE and transferred to 
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PVDF membranes for blotting. The following antibodies were used: mouse monoclonal 
anti RNase H1 (H00246243-M01, Novus Biologicals, Littleton, CO); rat monoclonal anti- 
tubulin (NB600-506, Novus Biologicals, Littleton, CO); mouse monoclonal anti- phospho 
(Ser 139) H2AX (05-636, Millipore, CA).  
 
Metaphase Chromosome Preparation  
Metaphase chromosomes were prepared as described previously (28). Briefly, cultured 
RPE1 cells were treated with 0.5 μg/ml colcemid (Sigma) for 6 hours. Arrested 
metaphase cells were collected by mitotic shake-off, treated with 75 mM potassium 
chloride, and fixed in 3:1 solution of methanol and acetic acid. Chromosomes were 
spread by dropping onto glass slides. For analysis via COFISH, 0.3 μg/ml 5-bromo-2’-
deoxyuridine (Sigma) and 0.1 μg/ml 5-bromo-2’-deoxycytidine (MP Biomedicals, Santa 
Ana, CA) were added to the cultured media 18 hours prior to collection of the cells.  
 
Chromosome Orientation - FISH (CO-FISH) 
CO-FISH was performed as described previously with modifications (29). Briefly, spread 
metaphase chromosomes were aged at 65 °C for 18 hours. Aged chromosomes were 
rehydrated in PBS, treated with 100 μg/ml RNase at 37 °C for 10 min and re-fixed in 4% 
paraformaldehyde at room temperature (RT) for 10 min. Fixed chromosomes were UV-
sensitized in 0.5 μg/ml Hoechst 33258 (Sigma) in 2X SSC at RT for 15 min and 
exposed to 365 nm UV light for 1 hour using a UV cross-linker (Vilber-Lourmat, Marne-
la- Vallée, France). Exposed chromosomes were digested with 3 units/μl Exonuclease 
III (Promega, Madison, WI) at RT for 15 min, denatured in 70% formamide in 2X SSC, 
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and dehydrated in cold ethanol before hybridization. Chromosomes were hybridized first 
using 0.03 μg/ml (PNA Bio, Thousand Oaks, CA) of a leading strand telomere PNA 
probe (FAM-(TTAGGG)3) followed by 0.03 ug/ml of a lagging strand PNA probe (Cy3-
(CCCTAA)3). Hybridized chromosomes were mounted using ProLong Gold (Life 
Technologies, Inc.) with 125 ng/ml DAPI.  
 
Microfluidic- Assisted Replication Track Analysis (maRTA)  
maRTA was conducted as described previously (30, 31). Briefly, asynchronous RPE1 
cells were labelled for 30 min each with 50 μM CldU and 50 μM IdU with two PBS 
washes in between. Labelled cells were collected and embedded in agarose plugs for 
lysis and DNA extraction. DNA was subsequently stretched, denatured and subjected to 
immunostaining. Antibodies used were rat anti-CldU/BrdU (Abcam, ab6326), mouse anti 
IdU/BrdU (BD Biosciences, 347580), goat anti-rat Alexa 594 (Invitrogen, A11007), and 
goat anti-mouse Alexa 488 (Invitrogen, A11001). 
 
Fluorescence Imaging  
Metaphase chromosomes from COFISH and labelled DNA tracks from maRTA were 
imaged on a Nikon 90i epifluorescence microscope using a 100 X 1.40 NA Plan Apo VC 
objective (Nikon Instruments, Meliville, NY) with Cargille Type LDF immersion oil 
*Cargille Sacher Laboratories, Cedar Grove, NJ). Images were captured using a 
CoolSnap HQ2 CCD camera (Photometrics, Tucson, AZ), deconvulated with a blind 
algorithm using NISElements AR (Nikon Instruments) prior to quantification. RPE1 cells 
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stably expressing GFP tagged WT and D145N RNH1 were visualized and captured 
without any staining.  
 
DNA immunoprecipitation (DIP)  
DIP was performed as described previously with modifications (6). Briefly, 293T cells 
were pelleted and resuspended in DIP lysis buffer (0.5% NP40, 85 mM potassium 
chloride, and 5 mM PIPES). Following centrifugation, pelleted nuclei were lysed in DIP 
nuclear lysis buffer (1% sodium dodecyl sulfate, 25 mM tris-HCl pH 8, and 5 mM 
EDTA), sheared and digested with two sequential rounds of 100 μg proteinase K for 1.5 
hours each at 55 °C. DNA was phenol:chloform extracted and ethanol-precipitated (32) 
at which point one half was subjected to an overnight digestion with recombinant 
ribonuclease H (Roche Applied Science, Penzberg, Germany). Samples were then 
diluted in DIP dilution buffer (1.1% Triton X-100, 0.01% sodium dodecyl sulfate, 1.2 mM 
EDTA, 16.7 mM tris-HCl pH 8, and 166.5 mM sodium chloride) and sonicated to 
generate about 200 bp long DNA fragments. Resulting DNA was quantified using the 
PicoGreen assay following the manufacturer’s protocol (Life Technologies, Grand 
Island, NY). 10 μg of DNA was immunoprecipitated overnight with 10 μg of S9.6 
antibody or mouse IgG. Antibody- DNA complexes were captured by using Protein A 
magnetic beads (Life Technologies, Grand Island, NY) after equilibration in DIP dilution 
buffer. After extensive washing, antibody- DNA complexes were eluted from the beads 
and treated with proteinase K followed by recovery using PCR cleanup columns 
(Qiagen, Venlo, Netherlands).  
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S9.6 Immunofluorescence (S9.6 IF) 
S9.6 IF was performed as previously described (9). Briefly, RPE1 cells transfected with 
siCtrl or siRNH1 were fixed with ice-cold methanol for 5 min at -20°C. Fixed cells were 
blocked in 2% BSA/PBS for an hour at room temperature followed by incubation with 
the S9.6 primary antibody (1:200 dilution, 1 ug/mL) and goat anti-mouse AlexaFluro-594 
conjugated secondary antibody (1:1000, Invitrogen) for 1 hour each at room 
temperature. Finally, cells were washed in 0.5 μg/ml Hoechst 33258 PBS to label the 
nuclei and mounted using ProLong Gold. Images were taken at 40X using a Nikon 90i 
epifluorescence microscope as previously described. Only the nuclear staining of S9.6 
signal was considered and analyzed using ImageJ 1.50i.  
 
Genomic Quantitative PCR (qPCR)  
Genomic qPCR was performed using Power SYBR Green Master Mix (Life 
Technologies, Grand Island, NY) following the manufacturer’s protocol. 5’ region of the 
Beta-actin pause element (5’ pause site), known to form RNA:DNA hybrids, was 
amplified to assess hybrid formation. Reaction conditions were as described in 
manufucturer’s instructions with 58.7 °C as the annealing temperature. Primers used 
were: 5′-TTACCC AGA GTG CAG GTG TG-3′ (Forward) and 5′-CCC CAA TAA GCA 
GGA ACA GA-3’ (Reverse).  
 
Quantitative Reverse Transcription - PCR (qRT-PCR) 
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qRT-PCR was performed as described previously (24). Target genes used were RNH1 
(Hs00268000_m1, Life Technologies, Inc.) and GAPDH (Hs. PT.39a.22214836, 
Integrated DNA Technologies). 
 
RESULTS 
RNH1 contributes to genome stability and preserves telomere integrity 
While RNH2 has well ascribed functions in the mammalian nucleus, RNH1’s role has 
remained more obscure. Because R-loops form throughout the genome and RNH1 can 
resolve R-loops that would pose barriers to the replication machinery, we hypothesized 
that RNH1 might play an important role in the nucleus and that its loss might perturb 
replication fork progression and thus elicit a DNA damage response (4). To test this 
hypothesis, we depleted RNH1 from normal, checkpoint-competent RPE1 cells and 
measured the levels of histone H2AX phosphorylation at S139 (ΥH2AX), a canonical 
marker of the DNA damage response (33) in control versus RNH1-depleted cells. 
Following RNH1 depletion, we observed increased levels of ΥH2AX, demonstrating that 
RNH1 depletion induces a DNA damage response (Fig 3.1A,B). These data suggest 
that RNH1 plays an important role in preserving genome stability. 
 
To further interrogate RNH1’s function, we first focused our attention to telomeres, 
chromosomal ends that contain RNA:DNA hybrids (34). Recent work demonstrates that 
in cells utilizing the alternative lengthening of telomeres (ALT) mechanism, which 
maintains telomere length independent of telomerase—RNH1 associates with 
telomeres and regulates the levels of telomeric RNA:DNA hybrids to prevent telomere 
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loss (22). In these cells, depletion of RNH1 led to hybrid accumulation and abrupt 
telomere excision. A second study suggested that RNH1 plays an important role in 
resolving RNA:DNA hybrids at the telomere (23). Because the leading strand replicated 
telomere is transcribed, RNA:DNA hybrids would be expected to form on the leading 
strand. Thus, we examined the integrity of the leading strand telomere by performing 
chromosomal orientation fluorescent in situ hybridization (CO-FISH), which allows one 
to interrogate the leading versus lagging strand replicated telomere. Surprisingly, CO-
FISH analysis revealed no differences in the leading versus lagging strand telomere in 
control versus shRNH1 cells (data not shown). However, in the RNH1-depleted cells, 
we observed a significant increase in telomere free ends (TFE), in which both leading 
and lagging strand telomeres were lost, a phenotype suggestive of DNA replication 
defects (35) (Fig. 3.1C,D). These data suggest that RNH1 assists the replication 
machinery by resolving RNA:DNA hybrids that could present a topological barrier to 
replication fork progression. 
 
Nuclear RNA:DNA hybrid levels increase upon RNH1 depletion 
To demonstrate that RNA:DNA hybrids were responsible for DNA damage and telomere 
loss phenotype upon RNH1 loss, we next measured those hybrid levels in the nucleus.  
We treated 293T cells with control (siCtrl) or RNH1 directed (siRNH1) siRNAs and 
collected cells 48 hours later. Transfection with siRNH1 led to a significant (2.5 fold) 
reduction in RNH1 mRNA levels (Fig. 3.2A) and (3.5 fold) protein levels (Fig. 3.2B) 
compared to levels present in siCtrl cells. To measure the amount of RNA:DNA hybrids 
in control versus RNH1-depleted cells, we next extracted nuclear DNA lysate and 
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subjected it to DNA:RNA immunoprecipitation (DIP) using the well characterized 
RNA:DNA hybrid antibody, S9.6 (36). We conducted a genomic quantitative PCR on a 
well-characterized hybrid forming 5’ pause site of beta-actin gene as a readout of hybrid 
signals. As a control for specificity, we also pretreated lysates with recombinant 
RNaseH enzyme in vitro to degrade existing RNA:DNA hybrids in both control and 
depleted cells. As expected, pretreatment with an in vitro RNaseH enzyme led to a 1.8 
fold reduction of RNA:DNA hybrids in control and a 3.5 fold in RNH1-depleted cells, 
confirming the specificity of the S9.6 antibody. Additionally, immunoprecipitation with an 
IgG control antibody failed to precipitate RNA:DNA hybrids, indicating that the signals 
we measured were bona fide RNA:DNA hybrids. Analysis of immunoprecipitations from 
RNH1-depleted cells revealed a significant two-fold increase in the nuclear RNA:DNA 
hybrids compared to those in control cells (Fig. 3.2C). To further corroborate these 
findings, we also utilized the S9.6 antibody and carried out immunofluorescence on 
RPE1 cells. As expected, RNH1-depleted cells showed increased levels of RNA:DNA 
hybrids as represented by elevated S9.6 signal in the nucleus compared to that in the 
control cells (Fig. 3.2D,E). Together, these data demonstrate that RNH1 depletion can 
lead to a significant increase in RNA:DNA hybrids and that this increase correlates with 
increased DNA damage and telomere loss. 
 
RNH1 depletion results in replication fork slowing and increased termination and 
stalling 
Given the increased RNA:DNA hybrids and DNA damage and loss of both telomeric 
ends, indicative of a replication defect following RNH1 depletion, we hypothesized that 
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RNA:DNA hybrids pose barriers to DNA replication forks. This hypothesis was 
supported by previous studies showing that the removal of RNA:DNA hybrids by 
ectopically expressed RNH1 can directly affect replication fork movement in yeast (37). 
To test this hypothesis, we used microfluidic-assisted replication track analysis 
(maRTA) to directly measure replication fork progression in RPE1 cells depleted of 
RNH1 (30, 38). RPE1 cells were transduced with siRNAs and cells were collected for 
western blot analysis 48 hours later. As expected, RNH1 depletion resulted in significant 
DNA damage as evidenced by increased ΥH2AX (Fig. 3.3A). In parallel, we carried out 
maRTA by plating RNH1-depleted or control cells and labeling them with the nucleotide 
analogs, CldU (red) and IdU (green), sequentially for 30 minutes each, to allow us to 
follow replication fork movement (Fig. 3.3B). To restrict our analysis to progressing 
replication forks, we measured IdU tracks that were directly preceded by a CldU track 
(Fig. 3.3B). Measuring the lengths of these IdU tracks, we found that RNH1 depleted 
cells had an average IdU track length of 9.3 (+/- 0.3) μm while that in the control cells 
was 14.5 (+/-0.4) μm, indicating that the replication forks moved significantly slower in 
RNH1 depleted cells compared to control cells (Fig. 3.3C). Given the increase in 
RNA:DNA hybrids associated with RNH1 loss, these data suggest that RNH1 facilitates 
efficient DNA replication by clearing RNA:DNA hybrids that would otherwise impede 
replication fork progression during S phase. 
 
To understand how the loss of RNH1 perturbed replication dynamics, we next asked 
whether other replication parameters including termination, stalling, and origin firing 
were affected upon RNH1 depletion. Premature termination and stalling events 
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correspond to CIdU (red)-only tracks (Fig. 3.3B). RNH1-depleted cells showed a 
significant 1.4 fold increase in termination and/or stalling events compared to control 
cells (Fig. 3.3D). Next, we analyzed the impact of RNH1 depletion on origin firing to 
address a possibility that slower fork progression triggers the S phase checkpoint and 
increases the frequency of origin firing as previously reported (39). To measure origin 
firing, the incidence of tracks with either green-only (IdU) color or red flanked by green 
on both sides was analyzed (Fig. 3.3B). However, no significant differences in origin 
firing were observed between RNH1-depleted and control cells (Fig. 3.3E). Collectively, 
these results indicate that RNH1 plays an important role in assisting fork movement 
during DNA replication. We suggest that RNH1 does this by resolving RNA:DNA hybrids 
that pose barriers to a progressing replication fork. Furthermore, our data provide the 
first evidence of RNH1’s role in global DNA replication in the mammalian nucleus. 
 
Nuclease activity of RNH1 is required for efficient replication fork movement 
To further characterize RNH1’s role in DNA replication, we tested whether the nuclease 
function of RNH1 was required for this activity. To do this, we created a series of RPE1 
cell lines ectopically expressing either a GFP-tagged wild type (WT) or a well 
characterized GFP-tagged nuclease-dead (D145N) form of RNH1 (26, 40). To establish 
a direct role in the nucleus, these RNH1 constructs lacked the mitochondrial targeting 
sequence present in the endogenous gene, thereby restricting their expression to the 
nucleus. We confirmed the nuclear localization of ectopically expressed proteins by 
visualizing GFP expression only in the nucleus (Fig. 3.4A). These stable RPE1 cells 
were transfected with an siRNH1 directed towards the 3’ untranslated region (3’UTR) 
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that did not target the ectopically expressed protein. We observed that RNH1 depletion 
using a 3’ UTR siRNA was comparable to that of a previously used coding sequence 
(CDS) targeting siRNA (Fig. 3.4B). We also observed robust expression of our 
ectopically tagged RNH1 proteins and significant depletion of endogenous RNH1 levels 
(Fig. 4B). Next, using maRTA, we again measured replication fork movement and found 
that ectopic expression of WT RNH1 restored fork movement to the levels observed in 
siCtrl cells (Fig. 3.4C). Indeed, while RNH1 depleted forks moved an IdU length of 8 μm, 
ectopic expression of WT RNH1 increased this to 12 μm, levels we observed in siCtrl 
cells.  In contrast, ectopic expression of the catalytically-dead D145N allele of RNH1 
failed to rescue the replication fork movement defect (fork movement was 7.9 μm, 
nearly identical to that observed in RNH1 depleted cells).  Together, these findings 
demonstrated that the nuclease activity of RNH1 is required for the unperturbed 
movement of replication forks in mammalian cells. Similarly, we also measured fork 
termination and stalling events upon ectopic expression of WT and D145N alleles in 
RNH1 depleted cells. As expected, both events were reversed by ectopic expression of 
WT RNH1 but not the nuclease dead allele, thereby reiterating the importance of the 
nuclease function of RNH1 in the fidelity of replication fork progression (Fig. 3.4D). 
Neither WT nor D145N alleles of RNH1 affected the levels of origin firing in RNH1 
depleted cells (Fig. 3.4E). These data suggest that the nuclease activity of RNH1 is 
required for resolution of RNA:DNA hybrids and therefore efficient movement of 
replication forks during nuclear DNA replication. 
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Discussion 
Our study establishes a role for RNH1 in genomic DNA replication. Indeed, we illustrate 
for the first time that RNH1 nuclease activity is required for efficient fork movement 
during nuclear DNA replication. Furthermore, we have established a correlation 
between the accumulation of RNA:DNA hybrids and replication defects observed upon 
RNH1 depletion. Taken together, we propose a model wherein RNH1 resolves 
RNA:DNA hybrids to assist the replication machinery in its uninterrupted movement 
during DNA replication. 
 
The unscheduled formation and stabilization of RNA:DNA hybrids have been postulated 
to be detrimental to the replication machinery.  The importance of resolving these 
structures is probably best underscored by the multitude of proteins that act on 
RNA:DNA structures. Indeed, helicases such as SETX, AQR, and DHX9 in mammalian 
cells and Sen1 and PIF1 in yeast have all been shown to resolve RNA:DNA hybrids (9, 
41, 42, 43). Here we add RNH1 to a growing list of proteins and show that endogenous 
RNH1 is required to similarly remove RNA:DNA hybrids and if these hybrids are not 
removed, replication is significantly impacted. Further our work demonstrates that these 
other proteins are unable to compensate for loss of RNH1 in replication fork 
progression. However, how RNH1 is regulated in the nucleus and how its activity is 
coordinated with the replication machinery remains unclear.  A recent study from 
Nguyen et al., elegantly demonstrated that RPA can interact with RNH1 and stimulate 
it’s activity raising the possibility that RNH1 is tightly regulated by the DNA replication 
and repair machinery (44). 
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Given that RNH1 loss elicits replication defects such as fork slowing and termination 
and fork stalling, it will be critical to determine how this impacts checkpoint activation 
and cell cycle progression. Furthermore, understanding the fate of accumulated 
RNA:DNA hybrids upon RNH1 depletion is another interesting avenue worth pursuing. 
As previously noted, RNA:DNA hybrids arising from different sources can be processed 
via separate mechanisms (9). For example, those involved in CSR are not processed 
via nucleotide excision repair (NER) whereas those arising from loss of some RNA 
processing factors or CPT treatment are processed by NER. It is also worth evaluating if 
redundant nucleases and helicases including RNaseH2, SETX, and AQR could rescue 
effects of RNH1 loss. 
 
The study of R-loops and their resolution have sparked more attention in recent years 
due to the fact that R-loops are associated with a number of diseases including cancers 
and several neurodegenerative disorders (45). This underscores a need for 
understanding these structures, their origins, stabilization and resolution along with their 
impact on cellular processes. By revealing RNH1’s function in R-loop resolution in the 
nucleus, our study adds to the diversity of mechanisms targeting such structures. 
Furthermore, our study identifies a previously unknown function of RNH1 in nuclear 
DNA replication. Together, our work broadens the understanding of RNA:DNA 
structures and places RNH1 as a novel mechanism to resolve those structures and 
assist in nuclear DNA replication. 
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Figure 3.1. RNH1 contributes to genome stability and preserves telomere integrity  
A. Western analysis of RNH1 expression (RNH1) and H2AX phosphorylation (γ H2AX) 
in control (shCtrl) and RNH1 depleted RPE1 cells (shRNH1). Bleo treated cells (Bleo) is 
a positive control for γ H2AX. α Tubulin is shown as a loading control. Molecular weight 
in kilodaltons is marked to the right for reference. B. Quantification of γ H2AX intensity 
in shCtrl and shRNH1 cells from western blot in A. C. Representative metaphase 
chromosomes processed with CO-FISH from shCtrl or shRNH1 RPE1 cells. Leading 
strand-replicated telomeres are green, and lagging strand-replicated telomeres are red. 
Regions marked by white asterisks are magnified; white arrowheads indicate telomere 
free ends (TFE) in magnified images. D. Representative quantification of telomere loss 
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in shCtrl and shRNH1 RPE1 cells. A minimum of 700 metaphase chromosomes were 
analyzed. p values were computed using a two-tailed Student’s t test (*, p<0.05). Error 
bars represent standard error of the mean. 
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Figure 3.2. Nuclear RNA:DNA hybrid levels increase upon RNH1 depletion 
A. qRT-PCR analysis of RNH1 mRNA in 293 T cells transfected with a control siRNA 
(siCtrl) or RNH1-targeted siRNA (siRNH1). Expression levels were calculated using the 
Ct method and normalized relative to GAPDH expression. B. Western analysis of 
RNH1 expression (RNH1) in control (siCtrl) and RNH1 depleted 293T cells (siRNH1). α 
Tubulin is shown as a loading control. Molecular weight in kilodaltons is marked to the 
right for reference. C. Quantification of the DNA:RNA immunoprecipitation (DIP) signal 
shown as a percent of input in siCtrl and siRNH1 293T cells. Pre-treatment of lysate 
with in vitro RNaseH (In vitro RNAH) enzyme serves as a control for RNA:DNA hybrids. 
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IgG is a non-specific antibody whereas S9.6 is a RNA: DNA hybrid-specific antibody. 
Analysis of 3 technical repeats from a representative experiment is shown. p values 
were computed using a 3-way ANOVA’s Sidak’s multiple comparisons test (*, p<0.05). 
Error bars represent standard error of the mean. D. Representative images of S9.6 
immunofluorescence on RPE1 control (siCtrl) and RNH1-depleted (siRNH1) cells. Blue 
staining marks the nuclei and red is S9.6 signal (RNA:DNA hybrids). E. Quantification of 
S9.6 signal (raw integrated density) (arbitrary units) for siCtrl and siRNH1 cells and 
shown is one of three independent experiments where a minimum of 80 nuclei were 
analyzed per sample. p values were computed using a non-parametric Mann-Whitney 
test (*, p<0.05). Error bars represent standard error of the mean. 
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Figure 3.3: RNH1 depletion results in replication fork slowing and increased 
termination and stalling 
A. Western analysis of RNH1 expression (RNH1) and H2AX phosphorylation (γ H2AX) 
in RPE1 cells transfected with siCtrl and siRNH1. α Tubulin is shown as a loading 
control. Molecular weight in kilodaltons is marked to the right for reference. B. 
Schematics showing labeling of cells for microfluidic- assisted replication track analysis 
(maRTA). Transfected RPE1 cells were labeled with base analogs CldU and IdU for 30 
min each and subjected to the maRTA protocol and DNA visualization in red (CldU) and 
green (IdU) by immunofluorescence (IF). Ongoing forks were marked by a red track 
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(IdU) followed by green (CldU); terminated and/or stalled were red-only tracks; origin 
firings were both green-only and red flanking green on either side. Representative DNA 
tracks for siCtrl and siRNH1 samples are shown. C. A representative quantification of 
three independent biological experiments showing the IdU track length (μm) preceded 
by a CldU track. Analysis included a minimum of 260 two-color DNA tracks (moving 
fork) isolated from siCtrl and siRNH1 cells each. p values were computed using a two-
tailed Student’s t test (*, p<0.05). Error bars represent standard error of the mean. D. 
Quantification of percentage of termination and stalling events in DNA isolated from 
siCtrl and siRNH1 samples. Mean from three independent experiments were analyzed 
and each analysis included between 210 and 260 DNA tracks per sample. p values 
were computed using a two-tailed Student’s t test (*, p<0.05). Error bars represent 
standard error of the mean. E. Quantification of percentage of origin firings in DNA 
isolated from siCtrl and siRNH1 samples. Graph represents combined means from 
three independent experiments that included between 275 and 350 DNA tracks per 
sample. p values were computed using a two-tailed Student’s t test (ns, p>0.05). Error 
bars represent standard error of the mean.  
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Figure 3.4: Nuclease activity of RNH1 is required for efficient replication fork 
movement 
A. Representative images verifying the nuclear localization (green) of ectopically 
expressed RNH1 in 293T cells transfected with a GFP-tagged wildtype RNH1 (WT) or 
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nuclease dead (D145N) allele. B. Western analysis of RNH1 expression (endogenous 
and ectopic) in RPE1 cells transfected with a control siRNA (siCtrl) or RNH1-directed 
(siRNH1) with or without ectopic expression of either GFP tagged wildtype (siRNH1+ 
WT) or nuclease dead (siRNH1+ D145N) RNH1. α Tubulin is shown as a loading 
control. Molecular weight in kilodaltons is marked to the right for reference. C. A 
representative quantification of three independent biological experiments showing the 
IdU track length (μm) preceded by a CldU track. Analysis included 265 to 280 two-color 
DNA tracks (ongoing fork) isolated from each of the four samples. p values were 
computed using a one-way ANOVA with Bonferroni multiple comparisons test (*, 
p<0.05; ns, p>0.05). Error bars represent standard error of the mean. D. Quantification 
of percentage of termination and stalling events in isolated DNA from all four samples. 
Mean from three independent experiments were analyzed and each analysis included 
between 240 and 350 DNA tracks per sample. Error bars represent standard error of 
the mean. E. Quantification of percentage of origin firings in DNA isolated from all four 
samples. Graph shown represents combined means from three independent 
experiments that included between 225 and 250 DNA tracks per sample. Error bars 
represent standard error of the mean. 
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Conclusions 
DNA replication and DNA repair are vital cellular processes that maintain genome 
stability. While numerous redundant mechanisms have evolved to ensure that these 
processes are faithfully executed, they are not immune to dysfunction and failure. When 
severe, such problems can result in genome instability, cell cycle arrest, senescence, 
and apoptosis (1), (2). Importantly, such manifestations are associated with a wide 
range of human pathologies from autoimmune diseases and cardiovascular diseases to 
muscular dystrophy and cancer. Therefore, understanding the molecular mechanism of 
DNA replication and DNA repair is critical for better understanding human diseases and 
developing therapeutics.   
 
To that end, my thesis work uncovers novel functions of two DNA replication and repair 
proteins. First, we show that human flap endonuclease 1 (FEN1), a structure specific 
endonuclease, is required for maintaining telomere stability. In particular, FEN1 loss 
elicits telomere fragility on the leading strand replicated telomere, a phenotype 
uncharacteristic of a lagging strand protein. Second, we discover that human 
ribonuclease H1 (RNH1), an RNA:DNA hybrid specific nuclease, facilitates nuclear DNA 
replication. We propose that RNH1 accomplishes this by resolving RNA:DNA hybrids 
that can present roadblocks to a moving replisome complex.  
 
FEN1 limits telomere fragility on the leading strand  
As described in chapter 2, we provide the first evidence that a lagging strand protein, 
FEN1, functions in leading strand DNA replication by preventing leading strand-specific 
	 130 
telomere fragility. This finding was in a stark contrast to a lagging strand specific 
telomere phenotype that our laboratory had previously reported where FEN1 prevented 
a sister telomere loss (STL) phenotype at the lagging strand (3), (4). Because 
RNA:DNA hybrids form at the leading strand telomere, we proposed that the fragility 
phenotype could be a result of a collision between the replication and transcription 
machineries (5). To test this hypothesis, we chemically inhibited transcription and found 
that telomere fragility was exacerbated suggesting that transcription was an important 
element of the fragility phenotype at the leading strand. Furthermore, we also identified 
that this phenotype was a result of RNA:DNA hybrids as evidenced by the rescue of the 
phenotype upon ectopic expression of RNH1 in FEN1-depleted cells. Finally, we 
showed that FEN1’s flap endonuclease activity, not its interaction with PCNA nor its gap 
endonuclease and exonuclease activity, was required to limit leading strand telomere 
fragility phenotype. Taken together, we propose a model wherein FEN1 limits leading 
strand fragility by using its flap endonuclease activity to cleave the RNA:DNA hybrid 
structures produced as a result of a replisome-transcription collision event.  
 
Human RNH1 limits R loops and facilitates DNA replication 
We report in chapter 3 a novel role of human RNH1 in the nuclear DNA replication. 
While human RNH1 is required for mitochondrial DNA replication, its nuclear function 
has remained unclear except at the telomere of ALT cells (6), (7). Given that RNA:DNA 
hybrids were abundant in the nucleus and that these topological structures could pose a 
challenge to a moving replication fork, we hypothesized that RNH1 loss may elicit 
replication defects. Upon RNH1 depletion, we first found a DNA damage response and 
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accumulation of RNA:DNA hybrids, suggesting that these structures are responsible for 
inducing DNA damage. We also analyzed metaphase chromosomes and found that 
RNH1-depleted cells had elevated levels of telomere loss in comparison to the control 
cells. This result was not surprising because of the important roles that RNA:DNA 
hybrids play to maintain telomere stability (8), (6), (9). This also suggested that this 
could be a result of replication fork collapse at the difficult-to-replicate telomere 
template. Thus, we proposed a hypothesis that RNH1 might be important in DNA 
replication outside of telomeres. To test that hypothesis, we utilized a single molecule 
DNA replication technique to examine DNA replication efficiency (10). We discovered 
that the replication forks slowed significantly upon RNH1 depletion. Similarly, replication 
termination and stalling events also increased upon RNH1 loss. Although we observed 
significant DNA replication defects, we were surprised that cells failed to activate the S 
phase checkpoint and cell cycle arrest in RNH1 depleted cells. This suggests that either 
RNH1 depletion is not significant enough to warrant a checkpoint arrest or that the 
RNH1 function is compensated by other ribonucleases. It is also possible that the check 
point activation is at a level undetectable by our current tools.  
 
Future Directions 
Structure and physiology of telomere fragility  
While telomere fragility results from several manipulations including TRF1 loss in mice 
and FEN1 loss in human cells as described in chapter 2, its structure composition and 
physiological relevance are largely unknown (11). First, to date, fragile telomeres are 
only described as abnormal telomeres that appear as multiple or smeared telomeres as 
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visualized on metaphase chromosomes. However, how such structures are formed and 
what proteins decorate and stabilize them remain unclear. Because visualization of 
some of the fragile telomeres using telomere specific PNA probes reveal a non-
telomeric sequences interspersed between two or more telomeric sequences, one might 
speculate such structures result from recombination between telomeric and non 
telomeric DNA sequences. It is also possible that those non-telomeric sequences are 
the sub-telomeric regions. Furthermore, whether such non-telomeric sequences are 
sequences of the same chromosome or different chromosomes remains to be seen. 
One way to address these questions would be to combine a telomere PNA FISH with a 
sub telomere DNA FISH on metaphase chromosomes. Because of the currently 
availability of chromosome-specific sub telomeric DNA probes, these experiments can 
reveal whether fragile telomeres are a result of intra-chromosomal or inter-chromosomal 
recombination or both (12). These experiments would also uncover if those non-
telomeric regions are sub telomeric sequences. Similarly, a lot of these structural 
identities of fragile telomeres could be revealed by a new generation of super-resolution 
microscopy. Another important question to investigate telomere fragility is to further 
explore the roles of RNA:DNA hybrids. Although we suggested that telomere fragility 
induced upon FEN1 depletion is RNA:DNA hybrid-dependent as evidenced by rescue 
upon ectopic RNH1 expression, we did not directly measure those levels. Future 
experiment could employ S9.6, an RNA:DNA hybrid specific antibody, to carry out an 
immunoprecipitation to directly measure hybrid levels.  
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A second set of intriguing questions regarding telomere fragility revolve around its 
physiological relevance. In other words, what is the significance of fragile telomere, if 
any? To begin to address this broad question, we could begin to ask specific questions. 
Are fragile telomeres stalled intermediates of a repair process? Or are these end 
products of a failed repair? Similarly, why would a cell form such structures? Is it a 
preferred damage state for cell survival? Some of these questions can be answered by 
beginning to closely look at the repair systems. One way to do this would be to utilize a 
genetic approach and knockdown or knockout proteins of both DNA replication and 
repair. However, such genetic knockdown experiments should be conducted with proper 
controls to avoid confounding results. For example, knockdown of Rad51, an essential 
homologous recombination protein, led to an increase in telomere fragility (12). This is 
counter-intuitive given telomere fragility is thought to be a recombination-dependent 
phenotype. However, it turns out that Rad51 is also required for telomere replication 
and capping. Furthermore, because telomere fragility occurs through several means as 
discussed earlier, it is possible that the mechanism of formation of such structures may 
dictate their physiological roles thereby further complicating attempts to discern such 
structures. To understand if fragile telomeres were stable or transient structures, our 
laboratory conducted a series of time-course experiments by utilizing low doses of 
aphidicolin to induce telomere fragility. Our unpublished and preliminary data show that 
this phenotype was rescued 48 hours later suggesting that cells have mechanisms to 
repair or resolve such structures. However, whether these findings apply to fragility 
induced by other mechanisms such as TRF1 loss remains to be seen.  
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Regulation of RNH1 during DNA replication 
Although we identified a novel function of RNH1 in DNA replication as discussed in 
chapter 3, a lot remains unclear about how RNH1 is regulated and how it functions in 
the nucleus. First, we show that RNH1 depletion slows down replication fork movement 
and increases termination and stalling events but how RNH1 is assisting the replication 
machinery is unclear. Is RNH1 always associated with the fork during replication? Or is 
RNH1 recruited to assist the fork only when the RNA:DNA hybrids are encountered? 
One way to address these questions would be to conduct an isolation of proteins on 
nascent DNA (iPOND) technique (13). This technique allows for the labeling of nascent 
DNA followed by the purification of all proteins associated with an active replication 
complex. PCNA, as an essential DNA replication protein, can serve as a positive control 
to identify if RNH1 behaves in a similar fashion. In fact, using iPOND, our preliminary 
data show that RNH1 associates with a moving replication fork. Regardless of whether 
RNH1 associates with an active replisome complex or not, identifying RNH1’s 
interaction partners might shed light on how it is regulated.  
 
Another important question revolves around how RNH1 functions in the nucleus to 
facilitate DNA replication. Although we show that RNH1 depletion elicits several DNA 
replication defects, how RNH1 does this is unclear. We only provide a correlation 
between increased hybrid levels and replication defects upon RNH1 depletion. It is 
possible that there could be indirect effects of RNH1 that we have yet to consider. One 
way to address this would be to inhibit replication by using aphidicolin, for example, and 
assess replication defects in control and RNH1-depleted cells. If replication defects we 
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observed upon RNH1 depletion are indirect effects, we can test a possibility that RNH1 
may work together with other nucleases to co-ordinate its function. Furthermore, it is 
worth exploring if depletion of other ribonucleases such as RNH2 or helicases such as 
SETX and AQR would elicit such replication defects. This would require conducting 
DNA replication studies as described in chapter 3 after depletion of these factors. 
Lastly, understanding how a cell responds to RNH1 depletion and associated replication 
defects can provide insights into its function. Because global DNA damage response is 
observed upon RNH1 depletion as evidenced by increase in gH2AX, it will be interesting 
to investigate the cell cycle checkpoint response. Examining checkpoint markers such 
as Chk1, RPA, Chk2, ATM, and ATR may open insight into the cellular stress response 
upon RNH1 depletion. It is possible that other nucleases or helicases discussed above 
may compensate for RNH1 function thereby preventing checkpoint response. 
Alternatively, accumulated hybrids upon RNH1 loss may be processed by DNA repair 
system without invoking checkpoint response in a manner slightly different than 
reported with hybrids that accumulate upon AQR depletion. 
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